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ABSTRACT
Understanding the relationship between the non-coding sequence of the genome and the
gene expression is one of fundamental goals of regulatory genomics. Perturbing certain lo-
cations in the non-coding DNA causes a disturbance to the precise spatial and temporal
expression of the genes. Gene regulatory mechanisms determine the amount of change in
the gene expression from variations in the sequence. Mathematical modeling of gene ex-
pression has been proven to be successful to establish a sequence-to-function relationship in
a context aware manner and provide mechanistic explanation of the gene regulatory pro-
cesses. In this thesis, we aspire to provide tools for understanding sequence-level encoding
of gene regulation by applying thermodynamics-based models. More specifically, we pro-
vide a probabilistic framework to develop deeper insights about current knowledge of a
gene’s regulatory mechanisms, objectively characterizing what a new experiment adds to
such knowledge and quantifying how ‘informative’ that experiment is. In order to elucidate
mechanisms of transcriptional regulation we use single nucleotide polymorphism data to
further investigate different mechanistic hypotheses and provide knowledge of systems-level
processes. We construct a probabilistic model to leverage our knowledge of transcriptional
regulatory networks and identify variations that lead to a significant change. Through this
work we not only advance the field of regulatory genomics, but potentially provide a path for
identifying variations in the DNA that significantly effect phenotype and lead to a disease.
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CHAPTER 1: INTRODUCTION
Rapid advances in sequencing technologies promise to lead us to a new era of personalized
diagnosis and treatment based on genomics [1]. One of the most pressing challenges in
this era will be to uncover the cellular and physiological impacts of DNA variations [2, 3],
especially non-coding variations. Understanding gene regulatory mechanisms is critical in
interpreting the genetic variations and their effects on human health [4]. The non-coding
region harbors the majority of DNA variations that are associated with complex traits and
common diseases, such as cancer, diabetes and Alzheimer’s disease [5]. The most challenging
task for researchers is to uncover the perturbed biological functions implicated by these DNA
variations. A vast majority of variations associated with complex traits and common diseases
fall in non-coding regions of the genome [5, 6, 7], and they can potentially impact gene
regulatory functions [8, 9, 10]. While statistical genetics approaches have proven invaluable
in short-listing such variants in specific disease contexts [11], to elucidate the mechanistic
basis of these variants one needs a detailed quantitative understanding of regulatory sequence
function that is often beyond state-of-the-art [12]. The field of computational genomics
aims to understand the non-coding region of the human genome by developing statistical
and mathematical models. The non-coding DNA contains sequences that act as regulatory
elements influencing the transcription of genes into protein products through a process called
transcriptional regulation.
1.1 CONCEPTS IN GENE REGULATION
The Human Genome Project (HGP) made history in 2004 by publishing the first high
quality map of a human genome (the germline DNA sequence passed from parents to offspring
via reproduction). This historic achievement came at the significant cost of $2.7 billion over
13 years and $100 million for a single genome in 2001. Since then, the cost of whole genome
sequencing (WGS) per genome has decreased dramatically year over year, to the point
where, in 2019, it costs just $1000 - a staggering 10, 000 fold reduction over the 2001 price
[13]. Aside from the biological utility for WGS increasing demand and driving cost down, the
main appeal underlying the demand for this technology lies in its potential to revolutionize
medicine; physicians could be empowered to make informed and precise medical decisions
on diagnoses and treatment on the basis of the patient’s unique genetic makeup, thereby
avoiding wasteful periods of trial and error that incur high cost, congest the health system,
and can prove tragically fatal. Furthermore, the low cost of the technology and the ubiquity
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of its adoption could facilitate the discovery of even more consequences of particular genetic
variants, leading to even better standard of care. Of course, to ascertain the consequence of
an individual’s given genetic makeup requires data variation in genetic makeup; thankfully,
the observed diversity emerges from variation in genomes at the genetic level.
The composition of the DNA sequences are two intertwining chains of bases (nucleotide)
of which there are only four kinds (Adenine - A, Guanine - G, Cytosine - C, Thymine - T);
the chain is mostly identical across individuals but varies at particular positions in the chain
- variations which we call genetic. The range of changes for genetic variations could be wide:
from a single base pair change in the DNA that we refer to as single nucleotide polymorphism
(SNP), to deletions or insertions of multiple nucleotide (indels) or larger structural variations
such as copy number variation and chromosomal rearrangement events.
Cellular processes are determined by the response of regulatory sequences in DNA to
signals from specific proteins called transcription factors (TFs), leading to up- or down-
regulation of gene expression [14]. A major class of regulatory sequences is that of cis-
regulatory modules (CRMs, also called enhancers): these are regions of DNA, about 500-
2000 base pairs long, harboring TF binding sites that control the transcriptional levels of
nearby genes. Variation of the DNA sequence in CRMs can affect gene expression, and has
been linked to developmental defects and disease [5]. Even minor variations, such as single
nucleotide polymorphisms (SNPs), in CRMs can have significant functional impact, such
as problems in fetal development [15]. The consequences of sequence variations depend on
various circumstances, such as the tissue that the gene is functional in, the regulatory network
or functional pathways that the gene is involved in, developmental stage, and other factors
[16, 7, 17]. Quantitative modeling of gene regulatory systems formalizes what is known
about a gene’s regulatory mechanisms and can predict the effect of variants in molecular
levels [18, 19]. Mathematical models that are formulated and validated on biological data
are capable of predicting the changed caused by variations to the sequence [20, 21].
1.2 THERMODYNAMICS BASED SEQUENCE-TO-EXPRESSION MODELS
Our ability to predict the impact of non-coding sequence variations on gene expression
is very limited, in part due to the complexity of CRMs, and in part because such impact
depends not only on the sequence itself but also the abundance and activities of relevant TFs
in the cellular conditions of interest. Statistical methods based on correlations among diverse
data types such as TF-ChIP, histone modifications, gene expression, etc. can reveal salient
properties of CRMs such as their tissue-specific activities [22] and their major regulators
[TFs] [23, 9], and can in some cases predict the effect of removing a TF’s influence on a
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CRM or gene [24, 25, 26]. Statistical and machine learning methods have recently been
developed that can to some extent predict the effects of single nucleotide mutations on
TF binding levels, DNA accessibility [27, 28], and even gene expression [29], but these are
typically not amenable to mechanistic interpretations, and are in a relatively early stage of
exploration.
On the other hand, biophysical models based on equilibrium thermodynamics that ex-
plicitly incorporate key interactions among TFs, DNA and the transcriptional machinery
have proven powerful for mechanistic understanding of the gene regulation process [18].
Thermodynamics-based modeling of gene expression reveals the precise mapping between
CRM sequence and the associated gene expression in a variety of cellular contexts, the so
called ‘readout’ of the CRM. These models provide a means to formalize our assumptions
about a CRM’s cis-regulatory logic, especially how its functional elements combine to reg-
ulate a transcriptional output [30, 31, 18, 32, 33, 34]. They can generate predictions that
can be empirically tested [35], e.g., by targeted misexpression or mutagenesis experiments.
Indeed, they have been used to predict effects of site mutations [20], and also promise
to provide precise, mechanistically grounded predictions of the effect of minor sequence
changes in CRMs [35]. Furthermore, these models can reveal ambiguities in our mechanis-
tic knowledge about a system given existing data; pinpointing these ambiguities helps with
choosing the future experiments that would best improve knowledge of the system. The
success of thermodynamic models has been demonstrated in the context of systems with
high-resolution gene expression measurements, such as early-stage Drosophila embryonic
development [31, 18, 32, 36].
1.2.1 Scaling the Gene Expression Level Measurement for TFs and Target Genes
Scaling of gene expression: The thermodynamics-based calculation of the GEMSTAT
model is given by the formula Zon
Zon+Zoff
(Equation 1 in He et al. [36]). This formula represents
the fractional occupancy of the basal transcriptional machinery (BTM), but not the gene
expression level. The expression of a gene in a cell type is merely proportional to this
fractional occupancy for that cell type. (Note: This is a feature of the Shea-Ackers model,
from which the GEMSTAT model was derived. The transcriptional initiation rate is assumed
proportional to the BTM occupancy, which then allows us to show that the equilibrium
mRNA level must also be proportional to that occupancy.) In other words, GEMSTAT is
incapable of modeling absolute expression levels. The modeling framework deals with this
by either defining the accuracy of the model (goodness of fit) as the correlation between
predicted and true expression levels across different cell types, or by assuming an unknown
3
constant of proportionality that must be multiplied with the predicted expression before
computing its deviation from true expression. (In the present work, we used the latter
approach.) In either case, the scaling of the gene expression levels before presenting them to
the model is irrelevant, and our results will be unchanged if we did not scale the expression
values to the range 0-1.
1.2.2 Scaling of TF Expression
GEMSTAT was designed to handle the variation of relative TF concentration levels across
cell types (e.g., positions along an embryonic axis), since this is what is commonly available.
The biophysics of TF-DNA interactions, on the other hand, needs to be formulated in terms
of the absolute TF concentration in a cell. Thus, where the model uses the term [TF ]
(concentration of TF in cell), we replace it with the term ν[TF ]rel, where is the relative TF
concentration in that cell. This leads to a free parameter ν for each TF, but it also means that
the [TF ]rel values can be input on an arbitrary scale. Thus our “scaling” the TF expression
level to a range of 0-1 is not necessary, and is merely a convenience for visualization.
Furthermore, it turns out that this additional free parameter per TF does not ultimately
add to the model complexity, for the following reason. The key formula modeling TF-DNA
interactions in GEMSTAT is the formula for the “statistical weight” of a site S for a TF,
whose optimal site is Smax, given by: q(S) = K(Smaxν[TF ]rele
LLR(S)−LLR(Smax)) (Equation
2 in He et al. [36]). Here, K(Smax) is the unknown TF-DNA binding constant for the
optimal site , Smax, ν[TF ]rel represents the TF concentration, and LLR(S) is the traditional
LLR score of site S. Note that the TF-DNA binding constant K(Smax) must be made a free
parameter for each TF. Note also that the two unknown constants K(Smax) and ν only occur
as a product and never separately, so for model inference purposes their product K(Smax)×ν
can be treated as a single free parameter. This product is in fact the free parameter that
we refer to as the ‘DNA binding parameter’ in the paper. Thus, the parameter ν that scales
the relative TF concentration to an absolute level does not cause an additional penalty in
terms of model complexity.
1.3 ENSEMBLE APPROACH TO UNDERSTAND THE MECHANISMS OF GENE
REGULATION
In-depth studies of gene regulatory mechanisms employ a variety of experimental ap-
proaches such as identifying a gene’s enhancer(s) and testing its variants through reporter
assays, followed by transcription factor mis-expression or knockouts, site mutagenesis, etc.
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The biologist is often faced with the challenging problem of selecting the ideal next exper-
iment to perform so that its results provide novel mechanistic insights, and has to rely on
their intuition about what is currently known on the topic and which experiments may add
to that knowledge. We seek to make this intuition-based process more systematic, by bor-
rowing ideas from the mature statistical field of experiment design. Towards this goal, we
use the language of mathematical models to formally describe what is known about a gene’s
regulatory mechanisms, and how an experiment’s results enhance that knowledge. We use
information theoretic ideas to assign a ‘value’ to an experiment as well as explain objectively
what is learned from that experiment. We demonstrate use of this novel approach on two
extensively studied developmental genes in fruitfly. We expect our work to lead to systematic
strategies for selecting the most informative experiments in a study of gene regulation.
1.4 QUANTIFYING THE EFFECT OF SINGLE NUCLEOTIDE VARIATIONS TO
DISTINGUISH MECHANISTIC MODELS OF GENE EXPRESSION
The non-coding genome exhibits a hierarchical organization of structural and functional
units, including large topologically associating domains or TADs at the megabasepair-scale
[37], accessible regions and enhancers at the kilobasepair-scale [38, 39] and transcription
factor (TF) binding sites at the basepair-scale. It is believed that a common mechanism
of variant impact on cellular function is by affecting TF binding site strength, and con-
sequently the gene expression level driven by an enhancer [40, 41]. Thus, to investigate
such mechanisms we need a precise quantitative method to predict expression level from
enhancer sequence, i.e., a “sequence-to-expression” model [30, 31, 32, 18, 33, 34, 36]; such
methods must be sensitive enough to predict the regulatory effect of relatively minor changes
in enhancer sequence, as is often the case with individual variations.
It is challenging to predict the impact of small genetic changes such as single nucleotide
polymorphisms on gene expression, since mechanisms involved in gene regulation and their
cis-regulatory encoding are not well-understood. Recent studies have attempted to predict
the functional impact of non-coding variants based on available knowledge of cis-regulatory
encoding, e.g., transcription factor (TF) motifs. In this work, we explore the relationship be-
tween regulatory variants and cis-regulatory encoding from the opposite angle, using the for-
mer to inform the latter. We employ sequence-to-expression modeling to resolve ambiguities
regarding gene regulatory mechanisms using information about effects of single nucleotide
variations in an enhancer. We demonstrate our methodology using a well-studied enhancer
of the developmental gene intermediate neuroblasts defective (ind) in D. melanogaster . We
first trained the thermodynamics-based model GEMSTAT to relate the neuroectodermal
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expression pattern of rho to its enhancer’s sequence, and constructed an ensemble of models
that represent different parameter settings consistent with available data for this gene. We
then predicted the effects of every possible single nucleotide variation within this enhancer,
and compared these to SNP data recorded in the Drosophila Genome Reference Panel. We
chose specific SNPs for which different models in the ensemble made conflicting predictions,
and tested their effect in vivo. These experiments narrowed in on one mechanistic model
as capable of explaining the observed effects. We further confirmed the generalizability of
this model to orthologous enhancers and other related developmental enhancers. In conclu-
sion, mechanistic models of cis-regulatory function not only help make specific predictions
of variant impact, they may also be learned more accurately using data on variants.
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CHAPTER 2: AN INFORMATION THEORETIC TREATMENT OF
SEQUENCE-TO-EXPRESSION MODELING
Studying a gene’s regulatory mechanisms is a tedious process that involves identification of
candidate regulators by transcription factor (TF) knockout or over-expression experiments,
delineation of enhancers by reporter assays, and demonstration of direct TF influence by site
mutagenesis, among other approaches. Such experiments are often chosen based on the biol-
ogist’s intuition, from several testable hypotheses. We pursue the goal of making this process
systematic by using ideas from information theory to reason about experiments in gene regu-
lation, in the hope of ultimately enabling rigorous experiment design strategies. For this, we
make use of a state-of-the-art mathematical model of gene expression, which provides a way
to formalize our current knowledge of cis- as well as trans- regulatory mechanisms of a gene.
Ambiguities in such knowledge can be expressed as uncertainties in the model, which we
capture formally by building an ensemble of plausible models that fit the existing data and
defining a probability distribution over the ensemble. We then characterize the impact of a
new experiment on our understanding of the gene’s regulation based on how the ensemble of
plausible models and its probability distribution changes when challenged with results from
that experiment. This allows us to assess the ‘value’ of the experiment retroactively as the
reduction in entropy of the distribution (information gain) resulting from the experiment’s
results. We fully formalize this novel approach to reasoning about gene regulation exper-
iments and use it to evaluate a variety of perturbation experiments on two developmental
genes of D. melanogaster. We also provide objective and ‘biologist-friendly’ descriptions of
the information gained from each such experiment. The rigorously defined information the-
oretic approaches presented here can be used in the future to formulate systematic strategies
for experiment design pertaining to studies of gene regulatory mechanisms1.
2.1 ENSEMBLE OF MODELS TO PREDICT GENE EXPRESSION
Mechanisms influencing the precise function of a regulatory system include the number,
accessibility, affinities and relative arrangement of TF binding sites within a CRM, as well
as cellular concentrations of the TF molecules, and protein-protein interactions; all of these
mechanisms affect the rate of transcription of the gene [43]. Thermodynamic models of
CRM function encode these mechanistic factors in their parameters, which correspond to
biochemical properties of the molecules controlling the gene expression. These parameters
are typically computationally optimized to be assigned values that can best explain the gene
1This work has been published in PLoS Computation Biology [42].
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expression patterns attributable to a set of CRMs [18, 36]. When used to investigate the reg-
ulatory function of a single CRM, the thermodynamic modeling approach faces a significant
challenge: non-uniqueness of the optimal models. For instance, a CRM mediating control by
five or more TFs will include 10 or more free parameters in the GEMSTAT thermodynamic
model [36] and we have shown previously that parameter training will converge to one of
many local optima [20]. Each optimal model explains the data equally well, but uses pa-
rameters that correspond to significantly varying, often mutually incompatible mechanistic
hypotheses [44, 45]. For example, consider a gene regulated by a CRM that is under the
control of two activators. Assume there are two models that explain the wild-type expression
pattern. One model predicts the correct expression by using (assigning function to) only one
activator, while the other model uses both activators. In the absence of additional biological
experiments that confirm the role of each activator, both models are equally plausible. Prob-
lems arise when we try to predict, using the model, the effect of knocking down an activator
or mutating its binding site(s). Depending on which model we use, the predicted effect of
the perturbation experiment is different: a model that does not use an activator will not
predict a change due to removal of that activator’s influence. However, there is no reason to
prefer one model’s prediction over the other, and the biology remains ambiguous until a new
experiment is performed. We believe it is important to respect this ambiguity of knowledge
when modeling gene expression data and making predictions about future experiments.
In agreement with the above proposal, Samee et al. [20] laid out a new paradigm of gene
expression modeling where one searches within the model’s parameter space for as many
optima as possible, resulting in an “ensemble” of optimal models. (Henceforth, different as-
signment of values to the model’s tunable parameters will be considered as different models.)
Each model in the ensemble is a hypothesis about the cis-regulatory mechanisms encoded
in the CRM, and is also capable of making specific predictions about perturbation exper-
iments. A simple approach to working with an ensemble of models is to make predictions
by uniformly aggregating predictions of its member models. It has been shown that this
“wisdom of crowds” approach can be effective: aggregated votes of many models can predict
the effect of site mutations more accurately than any individual model [20].
We noticed, however, that a typical ensemble of sequence-to-expression models, e.g., that
created by Samee et al. [20] in modeling embryonic expression of the Drosophila gene ind,
is not uniformly distributed in the parameter space. Rather, they are clustered in the
parameter space (Figure 2.1D), with models within a cluster predicting similar effects for a
particular perturbation, but each cluster’s consensus predictions being qualitatively different
from those of other clusters. Different clusters can have different ‘spans’, i.e., the extent to
which models in that cluster differ from each other quantitatively (in parameter values)
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while producing equally good fits to available data and essentially the same predictions for
future experiments. For instance, the cluster at the bottom of Figure 2.1D has greater span
than the cluster on the top-left, which is relatively tight. The span of a cluster pertains
to parameter sensitivity [44, 45] in that region of parameter space. Furthermore, different
clusters may have different representation (number of models) in the ensemble, and the
number of represented models may not correlate with the span of the cluster. This is because
we do not make strong assumptions about how the ensemble of models was obtained, beyond
that it is a collection of models that fit the available data and may be located in different
regions of parameter space. With these observations about ensembles of models, we sought
the most appropriate way to use ensembles for making predictions and for designing future
experiments. We describe here one such procedure that we developed and implemented,
which allows us to make predictions with ensembles of models, and also offers a principled
approach to experiment design in gene regulation studies.
Briefly speaking, our modeling approach involves (1) creating a large ensemble of models
that fit the available data accurately, following the sampling and optimization strategy of
Samee et al [20] and (2) defining a probability distribution over the parameter space such
that the ensemble of models represents regions of high probability and where each cluster of
models (roughly speaking, a distinct mechanistic hypothesis) has approximately the same
total probability as other clusters. This distribution provides a principled way for us to
make aggregated predictions about any particular perturbation experiment, and to describe
the uncertainty in such predictions. Additionally, we show how to measure the entropy of
this probability distribution, thereby quantifying the uncertainty in parameter space [46]
that remains after fitting the models to available data. Noting that the ensemble of models
consistent with available data changes (typically shrinks) upon performing an additional
experiment, we suggest that the difference of entropies of the probability distributions be-
fore and after an experiment (i.e., information gain) may be used to score the ‘value’ of
the experiment. We can use this value as a score to compare different experiments, the
experiment with greater score being deemed the more informative experiment. The ability
to assign information theoretically-grounded ‘values’ to experimental results is significant,
since it paves the way for principled experiment design [47, 48]
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2.2 CONSTRUCTION OF A PROBABILITY DISTRIBUTION OVER MODELS, AND
POTENTIAL APPLICATIONS
2.2.1 Outline of Gene Expression Model
We consider the class of mathematical models that predict the gene expression level driven
by a cis-regulatory module (CRM) from the latter’s sequence, given prior knowledge of rel-
evant transcription factors (TFs), their in vitro DNA-binding affinities (motifs), and their
concentration levels in the cellular context of interest. Several such models have been in-
vestigated in the literature [31, 18, 32, 35], and we work with the GEMSTAT model [36],
which we developed previously and which we are most familiar with. The GEMSTAT model
has two free (tunable) parameters for each relevant TF, one corresponding to its binding
strength for the consensus site and one corresponding to its potency as an activator or re-
pressor. The model also has optional free parameters for any TF-TF cooperative interactions
that the modeler may choose to include. Assigning values to these free parameters specifies
a model completely, allowing it to predict gene expression in any cellular context where TF
concentrations are known. Typically, optimization strategies are used to identify the param-
eter setting(s) that accurately predict gene expression driven by a CRM in multiple cellular
contexts [49].
2.2.2 Construction of Model Ensemble
In light of the observations made in Introduction, we sought to first construct an ensemble
of models that are widely spread in parameter space, and thus represent different mechanistic
explanations of data. A model is included if its goodness-of-fit score – sum of squared errors
or ‘SSE’ between known and predicted expression levels in multiple cellular conditions – is
below a threshold. We noted that the number of TFs in common modeling scenarios is less
than 10 [31, 18, 32, 35, 36], and the number of free parameters in the range of 10-20. This
led us to consider uniform sampling of the parameter space as the first step of ensemble
construction. We followed the approach of Samee et al. [20] (Figure 2.1 A-D), performing
extensive uniform sampling from the space (millions of samples), followed by filtering of
promising models (SSE score below a modest threshold), local optimization seeded by these
promising models, and a final round of filtering on the optimized models (SSE score below
a strict threshold). (See Methods for details.) This procedure allows us to construct a large
ensemble of models representing many or all optimal regions of the parameter space. We
provide more details of ensemble size and composition later (specific gene models).
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Figure 2.1: Schematic of Methodology (A) Each point in the scatter plot is a model with two
parameters denoted TF1 and TF2 and its color shows its ‘goodness-of-fit’ score (see color
legend on right). A number of models are uniformly sampled from the two-dimensional
parameter space and scored against available data. (B) Initial filtering of models in (A) for
a high goodness-of-fit score results in multiple clusters of models. (C) Models in panel B
are used as starting points for numeric optimizations of goodness-of-fit, resulting in multiple
clusters of locally optimal models. (D) A stringent threshold on goodness-of-fit is used to
filter optimized models (panel C) to obtain the final ensemble. (E) An ensemble of four
models in a one-dimensional space is represented by a uniform discrete probability distribu-
tion. (F) The same ensemble as (E), represented by a continuous probability distribution,
as a uniform mixture of Gaussian distributions centered at the four models. (G) Models are
recognized to fall in two clusters and the continuous distribution of (F) is modified to assign
equal weight to each cluster.
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2.2.3 Construction of Probability Distribution over Models
An ensemble of models can be used to make predictions by aggregating (averaging) the
predictions made by each member model. However, this approach ignores the fact that the
ensemble construction (outlined above or by a similar method) likely results in some regions
of parameter space being over-represented in the ensemble. Models belonging to the same
region, i.e., proximal to each other in the parameter space, are presumed to represent qual-
itatively similar mechanisms of CRM function. Thus, the ensemble’s aggregate predictions
may be biased towards one or a few mechanistic hypotheses. We therefore sought a more
nuanced way to aggregate model predictions, by defining a probability distribution over pa-
rameter space that captures how the fit models are spread across different regions of the
space but discounts for unequal representations of (number of models in) different regions.
Such a probability distribution can then be used to make predictions about new experiments
and also to score the uncertainty of mechanistic explanations offered by the ensemble. We
also note that constructing this distribution has close ties to the kernel density estimation
problem [50] but is different because the ensemble is not a collection of IID samples drawn
from the desired population.
The simplest distribution to consider is a discrete uniform distribution over the models in
the ensemble; e.g., Figure 2.1E shows such a distribution over an ensemble of four models
in a toy 1-dimensional parameter space. In the continuous parameter space, highly prox-
imal models are likely to have similar goodness-of-fit, therefore we smoothen the discrete
distribution by centering a Gaussian distribution at each model in the ensemble and con-
structing a uniform mixture (Figure 2.1F). This mixture of Gaussian distributions provides
a continuous distribution, but if one region of the space is over-sampled in the ensemble,
the distribution puts undue weight in that region; e.g., the three closely-related models on
the left in Figure 2.1F together carry about three times the probability mass as that around
the isolated model on the right. In light of this observation, we first cluster models, each
cluster roughly corresponding to a distinct mechanistic hypothesis, and define the overall
probability distribution to be a mixture of distributions representing each cluster. Since
we lack any additional knowledge to prefer one cluster over another, we assume uniform
mixture weights for the clusters. The probability distribution representing each cluster, in
turn, is a mixture of Gaussian distributions whose means are the models in that cluster.
Thus, Figure 2.1G shows a mixture of two distributions (red and blue) representing the two
clusters, with the red distribution in turn being a uniform mixture of Gaussians centered on
the three models in that cluster. Figure 2.2A shows a similar construction, now for a 2D
parameter space, beginning with the given filtered ensemble θ1, θ2, . . . , θM , identifying three
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Figure 2.2: (A-B) Illustration of an information theoretic value of an experiment: (A)
All models are assessed for goodness-of-fit on available (e.g., wild-type) data, an ensemble
θ1, θ2, . . . , θM is obtained (top) as outlined in panels A-D, and a probability distribution is
constructed (bottom), shown here for a two-dimensional parameter space. (B) Models in
the wild-type ensemble are further examined for goodness-of-fit on new experimental data
(e.g., a site mutagenesis experiment), and fit models are retained to construct a new filtered
ensemble (top) and the probability distribution is recomputed (bottom). (C) Entropy scores
of the probability distributions of the wild-type ensemble and filtered ensemble are computed,
denoted by Hwt and Hmut respectively, and the information gain is computed as the difference
of these two entropy scores.
clusters and constructing the mixture probability distribution. (For more details, especially
the construction of co-variance matrices for these distributions, see Methods.)
2.2.4 Potential Applications
The probability distribution over models, constructed as above, can be used in the follow-
ing ways:
1. Aggregating ensemble predictions: Each model in the ensemble makes a prediction on
unseen data, i.e., the gene expression level driven by the modeled enhancer(s) in a
cellular context described by TF concentrations. The ensemble’s aggregate prediction
can be computed by averaging predictions of all models weighted by their probabilities
as specified by the distribution.
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2. Quantifying uncertainty of ensemble predictions: The probability distribution makes it
possible to quantify the variance in ensemble predictions on unseen data. This variance
represents the uncertainty among ensemble models with respect to that data point.
3. Assigning objective ‘value’ to an experiment: We can utilize the probability distribu-
tion over an ensemble to measure the information theoretic value of an experiment.
Given new data, i.e., results from a new experiment, we can filter models to obtain a
smaller ensemble that agrees with the new data, henceforth called the ‘filtered ensem-
ble’ for the experiment. Using the fact that the entropy of the probability distribution
captures the uncertainty intrinsic to the ensemble, we can use the difference in entropy
of the original ensemble and the filtered ensemble, also called the ‘information gain’,
as an objective evaluation of how informative the experiments results are. (Details of
entropy calculation for a given probability distribution are provided in Methods, but
see Figure 2.2A,B for an illustration.) This approach ultimately allows, though we do
not explore it here, principled experiment design where the experiment whose results
are expected to result in the greatest information gain, is selected for follow-up.
2.3 AN INFORMATION THEORETIC MEASURE OF THE ‘VALUE’ OF AN
EXPERIMENT
Sequence-to-expression models enable us to propose mechanisms for gene expression reg-
ulation, that may then be confirmed by performing perturbation experiments such as TF
knockout or site mutagenesis, followed by expression assays that inform us about how the
gene expression changes in the perturbation condition. Some experiments result in greater
gene expression changes than others, and it is natural to want to characterize ‘what was
learned’ from each experiment, as well as quantify how informative that experiment was.
Here, we demonstrate such an exercise in systematic experimentation in the gene regulation
context, using the ensemble modeling framework described above.
Our first set of demonstrations are in the context of the regulatory mechanisms of an early
development gene in D. melanogaster - the intermediate neuroblasts defective (ind) gene.
We chose this gene because it is known to be regulated by a well-defined enhancer, and its
major regulatory inputs are well characterized. The gene was characterized by Weiss et al.
[51] and Stathopoulos and Levine [52], among others, and was the subject of systematic
modeling by Samee et al. [20]. It is expressed in a lateral stripe along the dorso-ventral
axis of the early embryo (S1A Fig, black curve), with activation from the TFs Dorsal (DL)
and Zelda (ZLD), and repression by the TFs Snail (SNA), Ventral nervous system defective
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(VND) and Capicua (CIC) (S1A Fig). In addition to the wild-type expression pattern of this
gene, its expression has been experimentally recorded under several perturbation conditions
(S1 Table), surveyed by Samee et. al [20] and further discussed below.
Despite the knowledge of a fairly complete set of regulatory inputs, several ambiguities
remain about the cis-regulatory logic of the ind enhancer. This is evident when we construct
an ensemble of models that predict the known expression pattern of ind from its enhancer
sequence along with TF concentration profiles along the D/V axis. Figure A.1B shows
that the ensemble’s mean prediction (magenta curve) for these wild-type conditions fits the
wild-type expression profile accurately, and with little variation among different models (pink
curves are models in the ensemble) but Figure A.1 C reveals that most of the 13 parameters of
the model exhibit substantial variability, a point also illustrated by the marginal distributions
of ten of the parameters (S1D-F Figs). The high degree of uncertainty is not surprising, given
that data from only one experiment – the wild type condition – for a single enhancer was
used to train the ensemble. It also means that results of various perturbation experiments
may prove informative about this gene’s regulatory mechanisms, an avenue that we pursue
next.
First, we worked with a ‘synthetic true model’ MST that allows us to predict results of
various perturbation ‘experiments’ in silico. This synthetic true model MST was carefully
chosen from among the ensemble of models consistent with wild-type data, described above.
(See S3 and S4 Figs for details.) We used MST to individually predict the effects of (a) each
TF’s knockout and (b) removing the strongest site of each TF in the enhancer, and treated
these predicted gene expression patterns (Figure 2.3 A, green curves) as the ‘true’ results of
those hypothetical or ‘in silico perturbation experiments’. We used each of the 10 in silico
experiments to construct a ‘filtered ensemble’ (average predictions shown in Figure 2.3 A,
magenta curves), computed its entropy score, and thus assigned an information theoretic
‘value’ to the experiment (Figure 2.3 B). We noted that the magnitude of change in the
expression profile resulting from a perturbation experiment does not necessarily reflect the
value of the experiment. For instance, it is possible to obtain new information from a
perturbation experiment where the expression pattern remains unchanged from wild-type, a
case in point being the SNA knockout experiment (Figure 2.3 A), with assigned value 1.66
- apparently many models consistent with wild-type data cannot explain this experiment
and are removed in the filtered ensemble from its results. Conversely, an experiment with
a more substantial expression profile change may not add anything to our knowledge of the
regulatory mechanism. For instance, the DL knockout experiment shows peak ind expression
diminishing by ≈ 60% (Figure 2.3A) but is assigned a value of 0.32 (Figure 2.3B), among the
lowest of the 10 experiments; this is because most models capable of explaining the wild-type
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Figure 2.3: Evaluating in silico experiments with a ‘synthetic real’ model MST. (A) The
model is used to generate synthetic ‘experimental’ results of TF knockout (top row) or
strongest site mutagenesis (bottom row), for each TF, shown in green. These are compared
to the synthetic ‘wild-type’ expression profile of ind, shown in black (in each panel). Magenta
curves show the average prediction of the filtered ensemble for each of these ‘experiments’.
(B) Each of the ten synthetic ‘experiments’ (panel A) is assigned a value, which is defined
as the information gain due to that experiment. (C) Entropy of filtered ensemble for each
of the ten ‘experiments’, as defined under the specially constructed probability distribution
presented in this work (Y axis) or under a discrete uniform distribution (X axis).
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ind pattern apparently use DL as activator, so knocking out DL does not provide much new
information. The same is not true of the experiment where the strongest DL site is removed,
an experiment with minor impact on expression (Figure 2.3 A) but a relatively high assigned
value of 1.34. This points out that even if the involvement of a TF is beyond doubt, there
may be uncertainty regarding the strength of its regulatory input and the mediatory role
of each of its binding sites. We noted (Figure 2.3 B) the same trend – that the value of
strongest site mutagenesis is greater than that of TF knockout – for the other activator
(ZLD). On the other hand, for perturbations involving repressors (SNA, VND, CIC) the
value of the site mutagenesis experiment is less than that of TF knockout in all three cases.
Also, for comparison, we show in Figure 2.3 C the relative values of the 10 ‘experiments’
under a more simplistic scheme that evaluates each experiment by the reduction in entropy
assuming a discrete uniform distribution on all models in an ensemble. We note that the
two schemes largely agree with each other in this evaluation, though this may not be true
in general, depending on how an ensemble of models is generated. Finally, we note that the
observations above were made with a specific choice of the ‘synthetic true model’ MST, that
furnished ‘experimental’ results, but the reported trends, e.g., large information gain from
a perturbation experiment with little effect on expression, or little gain from an experiment
with large effect, were unchanged when we repeated the entire exercise with a different choice
of MST ( S5 and S3B Figs).
2.4 EVALUATING PERTURBATION EXPERIMENTS ON IND GENE
REGULATION, EX POST FACTO
In this section, we will examine results of real perturbation experiments pertaining to
the ind gene reported in the literature and evaluate each experiment in the way described
above. In addition to the wild type gene expression pattern of the ind gene (S1A Fig),
we have information from six different biological perturbation experiments (S1 Table). It
is known that ind expression is abolished in DL mutants [53] and becomes weaker in ZLD
mutants [54]. Its peak expression reduces to 50% of its wild-type level upon mutation of the
four strongest ZLD binding sites [20]. (We call this experiment ‘ZLD site mut.’.) Removal
of the strongest DL site (‘DL 1 site mut.’) has no observable effects on the expression
[55] and removing three overlapping DL sites (‘DL 3 site mut.’) greatly diminishes peak
expression [20]. Knockout of SNA (experiment ‘SNA KO’) leaves ind expression unaltered
[32], while knocking out VND (‘VND KO’) causes the domain of expression to expand
ventrally [56], and CIC site mutagenesis (‘CIC site mut.’) expands ind expression dorsally
[57]. We evaluated each of the six perturbation experiments (two TF knockouts and four
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Figure 2.4: (A) Information gain score assigned to each of six perturbation experiments
involving regulation of the ind gene. These include four site mutagenesis experiments (four
left bars) and two TF knockout experiment (two right bars). (B) Entropy of filtered ensemble
for each perturbation experiments, as defined under the specially constructed probability
distribution presented in this work (Y axis) or under a discrete uniform distribution (X
axis).
site mutagenesis experiments) using the approach introduced in the previous section – begin
with the ensemble of models that explain wild-type gene expression, construct a filtered
ensemble that additionally explains the perturbation results (see Methods and Figure 2.2),
and calculate the difference in entropy (‘information gain’). The values assigned to these
experiments are shown in Figure 2.4A, and we note that the SNA and VND knockout
experiments were the most informative in this group.
Evaluating a new experiment, in our scheme, involves ruling out from the original en-
semble a subset of models inconsistent with that new experiment. Recall that models in
the ensemble were clustered, with the informal understanding that each cluster represents
a distinct mechanistic hypothesis. Thus, if an entire cluster is ruled out by a particular
experiment, one may interpret it as ruling out a particular mechanistic hypothesis. Table 1
shows the sizes of clusters in the original (wild-type) ensemble of models and the effect of
filtering with each perturbation experiment. We note that an experiment (‘DL 3 site mut.’
in Table 1) may remove just one cluster, while retaining other clusters of models as feasible.
There may also be experiments (‘SNA KO’ and ‘VND KO’ in Table 1) that rule out the
majority of mechanistic hypotheses, retaining only 2-3 of the original clusters. The other
scenario – where all clusters are retained but rendered substantially sparser – is also seen,
indicating that the information gained by those experiments was more along the lines of
quantitative refinement rather than qualitative pruning of the space of possible mechanisms.
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Figure 2.5: (A-C) Known effect of the ‘DL 1 site mut.’ experiment (A, shown in green,
compared to wild-type in black) is better predicted by the filtered ensemble for the experi-
ment ‘CIC site mut.’ (B) than by the wild-type ensemble (C). In B, C, ensemble predictions
shown as thin red lines and their mean shown in thick pink. (D-F) Known effect of the
‘CIC site mut.’ experiment (D) is better predicted by the filtered ensemble for the ‘DL 1
site mut.’ experiment (E) than by the wild-type ensemble (F), which shows greater variance
and disagreement across models. (G-I) The ‘SNA KO’ experiment has been observed to not
affect ind gene expression pattern (G). In contrast, majority of the models in the wild-type
ensemble (H) predict substantial ventral de-repression, but an ensemble filtered by the ‘VND
KO’ experiment predicts far less change in the ventral domain of ind expression profile.
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Figure 2.4B shows the above information theoretic evaluation of each experiment, compared
to a simpler scoring scheme where entropy of an ensemble is simply the logarithm of the
size of that ensemble, i.e., where we assume a uniform discrete distribution on models. As
expected, the two scores are highly correlated.
Table 2.1: Models in the wild-type ensemble can be clustered into 8 different groups based
on their parameter values, each cluster roughly corresponding to a distinct mechanistic
hypothesis. Given information from a new experiment, we filter the wild-type ensemble for
models that are predictive of the experiment outcome. Shown here are the sizes of clusters
of models in the wild-type ensemble, and their corresponding sizes after filtering for each of
six different perturbation experiments. The total number of models in each ensemble, the
corresponding entropy score and information gain score are shown in the last three columns.
Ensemble
1 2 3 4 5 6 7 8 Total Entropy
Information
Gain
Wild-type 433 921 425 711 680 744 552 771 5237 3.55 0
DL 1 site
mut.
111 239 112 169 203 215 286 98 1433 2.91 0.64
DL 3 site
mut.
122 45 115 0 225 282 96 437 1322 2.96 0.59
ZLD site
mut.
2 32 17 55 2 21 31 28 188 2.04 1.51
CIC site
mut.
35 2 33 1 0 0 7 284 362 1.79 1.76
SNA KO 1 0 0 0 0 0 0 34 35 1.07 2.48
VND KO 3 0 1 0 0 0 0 94 98 1.29 2.27
Note that experiments were assigned values above under the assumption that they were
the sole (or first) perturbation experiment performed. In reality, of course, a line of enquiry
proceeds via a series of such experiments, begging the question whether a perturbation ex-
periment can be informative on its own but not so much if it follows another perturbation
experiment. We explored this question further, by examining every possible pair of experi-
ments (performed sequentially), and noted that there are indeed such examples. However, in
the interest of continuity we do not discuss this analysis here, referring the interested reader
to Supplementary Table A.3.
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2.5 INTERPRETING THE INFORMATION GAINED FROM AN EXPERIMENT
We next moved beyond asking ‘how much’ information was gained from an experiment
to the more subjective question of ‘what’ information was gained. To answer this, it seems
natural to compare the original (wild-type) ensemble of models to the filtered ensemble that
is additionally consistent with the new experiment’s results. The challenge then becomes:
how do we compare these two ensembles in a language that appeals to the biologist’s intu-
ition? One pragmatic approach that we devised, and illustrate here, is to identify a second
experiment for which the two ensembles make markedly different predictions, and use this
difference to illustrate the distinction between ensembles. For instance, consider the ‘CIC
site mut.’ experiment, which we saw above to be of modest information theoretic value (Fig-
ure 2.4A). We also noted in Table 1 that this experiment induces a filtered ensemble with
two of the eight original clusters completely ruled out and two additional clusters drastically
reduced in size (from 900 and 700 models to 2 and 1 models respectively), suggesting
that certain plausible mechanistic hypotheses were indeed ruled out by it. To interpret this
further, we considered the predictions of this filtered ensemble on the ‘DL 1 site mut.’ ex-
periment (Figure 2.5C) and found these to be in fair agreement with the true results from
the literature [55] (Figure 2.5 A). We then noted that the wild-type ensemble, not filtered by
the ‘CIC site mut.’ experiment, is far more uncertain in its predictions about the ‘DL 1 site
mut.’ experiment (Figure 2.5B). Thus, the ‘CIC site mut.’ experiment informs us, correctly,
that mutagenizing the strongest DL site in the enhancer should not result in a significant
reduction in peak ind levels, a point that was ambiguous in the original ensemble.
A similar approach can be adopted to interpret the information provided by other pertur-
bation experiments. In our second example, we interpreted the ‘DL 1 site mut.’ experiment
by examining the predictions of its filtered ensemble on the ‘CIC site mut.’ experiment,
which according to the literature [57] shows an extension of the dorsal boundary of ind
expression (Figure 2.5D) This derepression effect is much more accurately predicted by the
filtered ensemble (Figure 2.5E), while the original ensemble’s average prediction is less defini-
tive in predicting this effect (Figure 2.5E). In other words, the ‘DL 1 site mut.’ experiment
informs us that CIC is an important repressor of the ind gene, setting up its precise dor-
sal boundary. For our third example, we note that the filtered ensemble of the ‘VND KO’
experiment accurately predicts that a genetic knockout of SNA will not affect the ventral
boundary of ind expression (Figure 2.5F,G), while the original ensemble erroneously predicts
ventral de-repression (Figure 2.5H). In other words, the ‘VND KO’ correctly informs us that
SNA does not position the ventral boundary of ind expression. Thus, these three examples
show how the information gained by an experiment can be interpreted by examining unique
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aspects of predictions of that experiment’s filtered ensemble on a second experiment.
2.6 QUANTIFYING AND INTERPRETING THE VALUE OF PERTURBATION
EXPERIMENTS ON THE SIM ENHANCER
Similar to ind, single minded (sim) is dorso-ventral patterning gene in D. melanogaster
that has been the subject of many biological experiments that describe the regulators of
the gene, delineate its enhancer [58, 59, 60], and characterize the combinatorial action of
multiple TFs and cell signaling in the formation of the precise expression pattern driven by
the sim enhancer [61]. The sim gene is initially expressed at the cellular blastoderm stage
in a narrow row of width equal to two cells along the dorso-ventral axis at the mesectoderm
(the boundary between mesoderm and neural ectoderm) [59, 60] (Figure 2.6A). sim acts as
a master regulator during the development of central nervous system (CNS) [62] and the
confinement of its expression to the narrow line of cells is essential for the formation of the
ventral midline and CNS during gastrulation [58, 63]. This precise pattern of expression can
be explained by a complex regulatory mechanism that involves Notch signaling [64, 65, 66].
On the ventral side, DL and Twist (TWI) activate but SNA represses the expression in
the mesoderm [58, 63]. Expression on the dorsal side is inhibited directly by Suppressor
of hairless (Su(H)), which is the only known repressor of sim in the neuroectoderm [64],
but is believed to have an activating influence on sim in the mesoderm region [56, 64, 67,
68]. With these pieces of mechanistic information in hand, we employed GEMSTAT to
model the expression driven by the sim enhancer. Then, we used the procedure introduced
above to examine different perturbation experiments related to this enhancer reported in
the literature, and quantify and interpret the ‘value’ of these experiments, after the fact. To
our knowledge, this work is the first attempt to computationally model the expression of the
sim enhancer, using the combinatorial action of TFs and signaling [64, 66, 69].
We built an ensemble of models that predicts the wild-type expression profile of sim
accurately (Figure 2.6B and Methods) from its wild-type enhancer (‘2.8sim’). We then con-
sidered several experiments reported in the literature pertaining to this gene, with the goal
of computing the information gain from each experiment and interpreting the information
they provide. Each of the nine experiments considered is a reporter assay with a variant of
the wild-type sim enhancer, and we used its observed readout to construct objective criteria
(S2 Table) for filtering models and creating a ‘filtered ensemble’ for that experiment (S6
Fig). This allowed us to quantify the information gain score of each experiment, using the
procedure described in previous sections (Figure 2.7A, B). This revealed that the experi-
ment ‘2.8sim∆SD16’, representing a deletion of two segments (harboring a SNA site and
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Figure 2.6: (A) Modeling sim enhancer. Expression profile of sim and all TFs that are
involved in sim regulation, shown for ventral-most bins 1-25 of the 50 bins along D/V axis.
Su(H) is modeled as both an activator and a repressor. (B) Ensemble of models that predict
sim expression profile accurately.
an E-box element respectively) from the wild-type enhancer 2.8sim, is the most informative
(value 2.25), while seven of the other eight experiments are substantially less informative
(about 0.5 or less). Following the procedure of the previous section, we then sought to
interpret the information gained by this experiment. This was most apparent when we
used the filtered ensemble of this experiment to predict the outcome of another experiment
(‘mesectoderm2.2’).
This second experiment is the reporter readout of a 2.2-kb sequence upstream of the
early sim promoter and overlapping with the wild type enhancer 2.8sim considered above
. According to the literature [69], the expression driven by this sequence is unchanged
(Figure 2.7C) from wild-type. The filtered ensemble of the ‘2.8sim∆SD16’ experiment [58]
can predict this known outcome accurately (2.7D), while the wild-type ensemble is far more
uncertain in its prediction (2.7E). The ‘2.8sim∆SD16’ experiment tests the effect of deletion
of SNA sites on the gene expression and restricting the wild-type ensemble based on results
of this experiment informs us which group of SNA sites is important to set up the precise
expression of the sim gene.
2.7 DETAILED DESCRIPTION OF THE ENSEMBLE ANALYSIS
2.7.1 Construction of Model Ensemble
We used the GEMSTAT model from [36] with 13 different parameters, including two
parameters for each of the five TFs: one pertaining to TF-DNA binding (KTF ) and one to the
TF’s effect on transcription rate (αTF ). Moreover, the model has one parameter for DL-ZLD
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Figure 2.7: (A) Information Gain from different perturbation experiments. Each experiment
represents the readout of a variant of the wild-type enhancer, under wild-type conditions,
and is named for the variant enhancer. (B) Entropy of filtered ensemble for each of the nine
experiments, as defined under the specially constructed probability distribution presented in
this work (Y axis) or under a discrete uniform distribution (X axis). (C-E) The ‘Mesecto-
derm2.2’ variant of the sim enhancer [69] (S2 Table) has been observed to recapitulate the
expression pattern of the wild-type enhancer (D). In contrast, majority of the models in the
wild-type ensemble (E) predict expansion of the dorsal boundary, but an ensemble filtered
by the ‘2.8sim∆SD16’ experiment predicts the known (non-)effect correctly.
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cooperativity (ωDl−Zld), and another parameter reflecting the baseline transcriptional rate
(qBTM). The repressor CIC has a uniform dorso-ventral expression profile but its repressive
effect is attenuated in the neuroectodermal region by locally activated ERK, through a
reduction in CIC-DNA binding; this effect, as modeled in [20], is represented by a free
parameter (Cicatt). The expression pattern of each TF and the ind gene was scaled in the
range of zero to one. Each expression profile is represented by a 50-dimensional vector (S1A
Fig), with dimensions corresponding to equally spaced bins along the D/V axis (bin 1 =
ventral end). The ind gene is expressed in only 5 to 7 of these bins (bins 22-28 with the
peak of expression at bin 25).
To construct the ensemble, we sampled models from the 13-dimensional parameter space
following the procedure of Samee et al. [20]. We divided the range of each parameter into two
halves (using log scale for K parameters of all TFs, α parameters of repressors and for qBTM
, and linear scale for: α of all activators, ωDl−Zld and Cicatt), and sampled 1000 points in
each cell of the 13-dimensional space, for a total of 8 million models. Such a dense sampling
was possible because the number of parameters (13) is modest. Among these randomly
generated models, we retained those with SSE (sum of squared errors) score between the
real and predicted ind profile less than 10%. This higher initial threshold allows us to get
good initial points. We then used GEMSTAT’s optimization routine to locally optimize the
initial ensemble, following which we filtered for models that have SSE score less than 5%.
This stricter error threshold was determined by a visual inspection of many examples, as one
that allows the main spatial pattern of expression to be preserved in the predictions meeting
that threshold (see S1 Appendix for further details). We call the resulting collection the
wild-type ensemble of models. It contains more than 5000 distinct parameter settings from
about 600 different regions, and all of these models make good predictions on the wild-type
data, as per visual inspection (Figure A.1 B).
2.7.2 Construction of Probability Distribution over Ensemble of Models
Each model is represented by its parameter vector, and we first scaled the parameters
using min-max scaling to place all the dimensions on the same scale of 0-1. The models
were then clustered based on a multivariate density estimation method, Mclust [70, 71],
using its R implementation. This method approximates the complete collection of models
as a (generally non-uniform) mixture of Gaussian distributions, each component Gaussian
representing a cluster, with its own mean (cluster center) and covariance matrix (S5 Fig),
while simultaneously determining the optimal number of clusters. Next, we modeled each
cluster C as a uniform mixture of nC = |C| Gaussian distributions with each of the nC models
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of the cluster as mean, and a common covariance matrix ΣC estimated for the cluster by the











N (θ;µiC ,ΣC) (2.1)
Here N is the number of clusters, C indexes these clusters, nC is the number of models in
cluster C, µiC is the i’th model in the cluster C, and ΣC is the covariance matrix of cluster
C.
Since models in the ensemble are not simply random samples of the probability distribu-
tion, but a collection of local optima obtained from initial random samples as seeds, we did
not use a standard density estimation technique to build a density function. (See Discussion
for our choice of the above methodology as opposed to more sophisticated sampling tech-
niques.) We expected the distribution to reflect the fact that each model is a local optimum
in the landscape of models scored by SSE measure and they group into several clusters.
These clusters reflect different hypotheses for the biological mechanism of the underlying
system and we desired that the probability density function put equal weights on them.
Within each cluster, it is possible to observe several equally good local optima (peaks of the
SSE landscape); we selected each such optimum as a local peak for the probability density
function as well, constructing a Gaussian Mixture with a fixed covariance matrix to repre-
sent a cluster, with component Gaussians centered on the optimized models in that cluster.
It is worth noting that our modeling of the desired probability distribution as a mixture of
Gaussian distributions has implicit ties to the ‘MaxEnt principle’, since the Gaussian is the
maximum entropy distribution under a given mean vector and variance/covariance matrix.
2.7.3 Entropy of Probability Distribution over Ensemble
We calculated the entropy function using a discrete version of the probability density
function in (1). The discrete probability piC of the model i in the cluster C is set to be
proportional to the value of the continuous probability density function at the location of
the model. Each piC receives contributions from all Gaussians in the mixture model. We set






is the number of clusters. We then estimated the entropy of this discrete probability density




i=1 piC log piC) [72].
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2.7.4 Information Gain from an Experiment
Suppose we are given an ensemble of models obtained from a set of experiments and have
calculated its probability distribution. We are then given the results of a new experiment.
This is typically in the form of gene expression level(s) driven by an enhancer sequence in
one or more cellular contexts described by their TF concentration profiles. We assess if
the predictions made by any model in the ensemble are consistent with these results, by
comparing the model’s predictions to the observed gene expression levels through a single
goodness-of-fit score such as SSE (sum of squared error), and discard that model if this
score is worse than a pre-determined threshold. Repeating this process for each model
in the ensemble, we obtain a ‘filtered ensemble’ that is a subset of the original ensemble.
We then modify the probability distribution over the filtered ensemble by (a) retaining
the cluster assignments and cluster covariance matrices of the original ensemble, but (b)
removing any cluster that has no remaining models and readjusting weights of remaining
clusters to add to 1, and (c) redefining the Gaussian Mixture Model for each cluster to
have component Gaussian distributions centered at each model remaining in that cluster
(also with uniform weights). Having thus defined a probability distribution over the filtered
ensemble, we calculate its entropy as above and assign the difference of entropy between the
(distributions over the) original and filtered ensemble as the information theoretic ‘value’ of
the new experiment.
2.7.5 Data sets for modeling sim enhancer
We constructed a one-dimensional vector to describe the expression readout of the sim
enhancer along the D/V axis, as recorded in the literature. This vector (and other expression
vectors described here) has 25 dimensions, representing equally spaced positions (‘bins’)
along the axis from the ventral end to the mid-point of the axis. (These are the same as
bins 1-25 of the 50 bins considered in previous sections.) The expression in each bin has a
value between 0 and 1 that corresponds to the relative amount of gene expression observed
in that bin. The expression profile of the wild-type sim enhancer was represented as a
Gaussian curve that has its peak at the location where SNA expression changes from high
to low (12th bin from ventral end), i.e., at the known location of the sim expression peak.
The variance of the Gaussian is set to be small enough that the ‘width’ of the expression
profile is similar to the narrow domain in which SNA goes from high to low (2.6A). We
obtained TF (protein) expression profiles of DL, TWI, and SNA from Zinzen et al. [32] and
represented them in the same 25-dimensional vector format as above (2.6A). We considered
27
DL and TWI as activators and SNA as a repressor. The other important regulatory input
considered was Su(H), which is a maternal protein uniformly expressed across the D/V axis.
It is believed to be a repressor, but Notch signaling activated by the effect of SNA on Notch-
Delta endocytosis switches the role of Su(H) from a repressor to an activator [64, 65, 66] in
domains of SNA expression (mesoderm). Since GEMSTAT does not allow for such a ‘role-
switch’ for any TF, we separated the uniform expression profile of Su(H) into two separate
profiles (vectors), one for each role: an ‘activator Su(H)’ with an expression profile similar to
SNA but extended to include the mesectodermal positions and a ‘repressor Su(H)’ with its
complementary profile. In this manner we capture the prior knowledge of the ‘role-switch’
of Su(H) at the peak expression of sim. The sim enhancer sequence and TF motifs, required
by GEMSTAT, were taken from Fly Factor Survey [73].
2.8 DISCUSSION
Determining regulatory mechanisms shaping the spatio-temporal pattern of a gene of inter-
est is a tedious process. While high throughput technologies provide helpful clues and narrow
the space of possibilities, the ‘gold standards’ for demonstrating the regulatory influence of
a transcription factor on a gene – a combination of TF knockout or overexpression (and
observed effects on gene expression), TF-DNA binding assays, site mutagenesis and rescue
experiments – involve substantial investments. Guidance about the most insightful experi-
ments to perform, given current knowledge about the gene’s regulation, can thus be highly
beneficial. Typically, such choices are made by the biologist by relying on their intuition.
We asked ourselves if the process of designing experiments to gain deeper understanding of
a gene’s regulatory mechanisms may be made systematic. This immediately presented two
major conceptual challenge: first, how do we formalize what is ‘current knowledge’ about
the gene’s regulation, and second, how do we measure how insightful or informative an ex-
periment is? Answers to these questions appear to be necessary before we could systematize
the process of experiment selection or design, mentioned above. In this manuscript, we take
present a possible solution to these challenging problems by making use of a previously es-
tablished quantitative modeling framework that relates trans- and cis-regulatory information
to gene expression levels, and combining the framework with ensemble modeling and infor-
mation theoretic ideas. In the future, our approach can be combined with well-established
ideas in statistical experiment design [47, 48] to develop a full-fledged formal approach to
investigation of gene regulatory mechanisms.
We approached the goal of formalizing current knowledge about a gene’s regulation by
using the GEMSTAT framework of gene expression modeling. (Other related models, e.g.,
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[74], would also have been similarly usable.) Here, current knowledge of a gene’s enhancer
sequence(s) and its known regulators (TFs) is encoded into a mathematical function that is
consistent with data on the gene’s and TFs’ expression levels in multiple conditions or cell
types. This not only forces the qualitative knowledge of regulators into a precise quantitative
form, it also explicitly captures complexities and subtleties associated with combinatorial
action of multiple TFs. Furthermore, the model has free parameters representing important
but often uncharacterized biochemical properties of the regulators, viz., free energy of DNA
binding and strength of regulatory influence, and the modeling step involves assigning values
to these parameters so as to match available data. In this step, one is often faced with many
distinct parameter settings that appear equally plausible in light of available data, and these
different parameterizations represent ambiguities in current mechanistic understanding of
the gene’s regulation, even when the likely regulators are qualitatively characterized. In our
approach, such ambiguities are explicitly catalogued in the form of an ensemble of models
consistent with data. To address the other conceptual challenge mentioned above (‘how in-
formative is an experiment?’), we compared the ensemble representing prior knowledge/data
to that representing new experimental data in addition to the prior information. It was nat-
ural to consider using the information theoretic ideas of entropy and information gain for
purposes of this comparison. We therefore devised an approach to define a probability dis-
tribution over models in the ensemble, and to estimate the entropy of the distribution; the
information gain was then defined as the difference in entropy of the two ensembles.
We demonstrated the use of our approach in the context of two genes in early fruitfly
development – ind and sim – whose regulatory mechanisms have been studied through
several perturbation experiments (TF knockouts, site mutagenesis, variant enhancers, etc.)
reported in the literature. In each case, we started with the wild-type enhancer and likely
regulators as ‘current knowledge’ and (retroactively) quantified how informative each of the
perturbation experiments is. We also presented objective observations about each experi-
ment that suggest the specific insights it added to our understanding of the gene’s regulatory
mechanisms. In the case of ind, we additionally applied our experiment-scoring framework
in a more controlled, semi-synthetic setting, where real data on the gene were used to first
select a unique model as the underlying ‘truth’, and used to provide the results of in sil-
ico perturbation experiments. We note however that the information gain values computed
by our method are not comparable across different studies, e.g., between the ind and sim
studies considered here; they are only comparable across different experiments for the same
gene, when evaluating those experiments for additional insights over a common set of current
data/knowledge.
Methodologically, an important feature of our approach was the generation of ensemble by
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uniform sampling in the multi-dimensional space, followed by optimization, as was done in
[20]. Alternative sampling algorithms can be used to generate a large sample from optimal
regions of the parameter space. Sampling methods such as Bayesian optimization techniques
can be used to efficiently search for optimal parameters of any given model with nonlinear
cost functions [75]. However, in practice these sampled optimal solutions may not be repre-
sentative of every possible region of the parameter space with similar goodness of fit. One
example of such a Bayesian optimization algorithm is the spearmint package. Spearmint,
when applied to our problem, produced only a few optimal models (data not shown). Build-
ing a large ensemble of models that represents every locally optimal region requires running
the method multiple times, which is very slow, due to slow convergence time [76]. The
spearmint method yields only few data points as the result of optimization and they are
usually close to each other. Unless we perform a detailed sampling around those points or
combine such techniques with a more global sampling approach, we do not have a diverse
ensemble to work with. On the other hand, since the number of parameters in our model
is small (less than 20), we could afford to do a dense uniform sampling of the parameter
space with our approach. Our ensemble generation process has ties to Bayesian inference,
as it constructs a distribution over models M, given data D. The more common approach to
this is to sample from the posterior distribution P(M—D), using a suitable likelihood model.
There are two reasons why we chose not to do this in our approach. First, we wished to im-
pose upon the distribution the property that different high-density regions of the space have
equal relative weights (probability mass), since each of these regions represents a distinct
mechanistic hypothesis to us. This property is technically challenging to encode in the form
of a prior distribution, and would require substantial research into the Bayesian inference
methodology, which was not our main focus. Second, we found that a standard Bayesian
optimization technique (which we tested) was not very efficient at sampling the parameter
space globally.
We believe that the framework established in this work can be used in future work to
formalize experiment design strategies for gene regulation studies. For instance, we may
compute the expected information gain [77] of various possible future experiments and select
the best one. Given a candidate future experiment, we may first use each in the current
ensemble to predict its outcome, compute the resulting information gain, and then compute
an expectation of this value over the entire ensemble, using the probability distribution
introduced in our work.
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CHAPTER 3: MODEL-BASED ANALYSIS OF POLYMORPHISMS IN AN
ENHANCER REVEALS CIS-REGULATORY MECHANISMS
3.1 UNDERSTANDING THE GENE REGULATORY MECHANISMS USING
ENSEMBLE OF MODELS
Sequence-to-expression models have been proposed in the literature to address the above
need [78]. These are mathematical models, based on biophysical principles [74] or machine
learning concepts [28, 27], that map an enhancer’s sequence, optionally along with additional
contextual information such as cellular concentrations and DNA-binding preferences of TFs,
to the expression level driven by that enhancer. These models formalize what is known
about a gene’s regulatory mechanisms encoded in enhancers, and have proven capable, in
some cases, of predicting the effects of minor sequence differences such as mutagenesis of
entire binding sites [18, 20, 21]. However, when using these models one is faced with a
trade-off in predictive accuracy: one fits the model to many different enhancers [36] if one
wishes to capture broad regulatory mechanisms, but the resulting models are not capable of
predicting the effect of minor changes such as single nucleotide variations. To achieve this
latter capability, one typically fits the model to fewer, more closely related enhancers [20],
but this results in under-constrained models and parameter uncertainty [42]. The result is
not a unique trained model but an ensemble of models, representing distinct mechanistic
explanations of the data, and thus an ensemble of predictions about the effect of the same
sequence mutation. If additional information becomes available about the true effect of an
enhancer mutation on gene expression, that information may be found to be consistent with
only a subset of the current ensemble of models and thus allow us to filter the ensemble
and reduce our uncertainty about parameters, consequently increasing our confidence about
cis-regulatory encoding of the enhancer. This is the key insight we pursue in this work.
We first used a thermodynamics-Based modeling framework to fit an ensemble of models
that relate the expression pattern of the gene intermediate neurons defective (ind) to the
known enhancer of the gene. Thermodynamics based models are among the most successful
genre of quantitative models for the sequence-to-expression relationship [18, 74], and for-
malize the enhancer’s cis-regulatory encoding through model parameters that are fit to the
available data. We had previously shown how ensemble modeling of the thermodynamics-
based GEMSTAT model [20, 42] can provide useful insights about the ind enhancer. Here,
we used the ensemble of models to predict the effect of each single nucleotide mutation in the
enhancer, and used our previously published probabilistic framework to identify mutations
with high expected impact and/or high variance in predicted impact. We experimentally
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tested the effect of such mutations, using transgenic reporter assays in fruitflies, and used
the resulting additional information to reduce the ensemble of models to a single tightly
clustered set of models that represent a unique mechanistic explanation of the enhancer’s
function. We then showed that the resulting model is indeed supported by additional data
not used in the modeling, e.g., it provides better fits to unseen enhancers related to the
ind enhancer. Our work attempts for forge a path forward towards deeper mechanistic un-
derstanding of the cis-regulatory ‘code’ [79] and its use in predicting the impact of single
nucleotide variants [80].
3.2 THERMODYNAMICS-BASED MODELING OF GENE REGULATORY
MECHANISMS
We set up the GEMSTAT model with 13 different parameters as in [20, 42] and trained the
model to relate the wild-type expression profile of the ind enhancer to the concentration pro-
files of the five TFs DL, ZLD, SNA, VND, CIC. GEMSTAT uses the following parameters:
KTF parameter indicating TF-DNA binding (one for each TF), αTF parameter to capture
the TF’s effect on transcription rate (one for each TF), and the parameter qBTM for the
basal transcriptional rate. Based on previous experimental studies [54], DL and ZLD work
cooperatively and this was modeled through the cooperativity parameter ωDL−Zld. Previ-
ously reported reduction in CIC-DNA binding by locally activated ERK is modeled using
the Cicatt parameter, as explained in [20]. Henceforth, we refer to any setting of values for
the above 13 parameters. We uniformly sampled the defined range of each parameter and
measured the SSE score between the wild-type and predicted expression profiles. We used a
loose threshold to filter for models with good fits (SSE< 0.15), used these models as start-
ing points for optimization (following GEMSTAT’s in-built optimization) and then selected
optimized models that meet a strict threshold (SSE< 0.05). The result is an ensemble of
5237 models with distinct parameter settings that produce high quality fits to the expression
profile of the gene. This is called the “wild-type ensemble”, as it was trained solely on the
wild-type expression profile.
Additionally, we utilized data from six different perturbation experiments pertaining to
ind gene expression in the same developmental stage as above. These biological perturbation
experiments included (i) ‘DL 1 site’ [55], where mutagenesis of the strongest DL site results
in no significant change of ind expression, (ii) ‘DL 3 sites’ [53], where mutagenesis of three
DL sites results in greatly diminished ind expression, (iii) ‘ZLD sites’ [20], where ind peak
expression reduces to 50% of wild-type levels upon mutagenesis of four ZLD sites, (iv)
‘SNA KO’ [32], where knock-out of SNA results in no significant change, (v) ‘VND KO’ [56],
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where knock-out of VND leads to ventral expansion of ind expression, and (vi) ‘CIC site
mut.’ [57], where CIC site mutagenesis leads to dorsal de-repression. Each of the 5237 models
in the wild-type ensemble was used to predict the effect of each of these six perturbation
experiments, and only those models whose predictions were consistent with data for at least
5 out of the 6 perturbations were retained (Supplementary figure A.13). Only 12 of the
5237 examined models met this requirement and none of these makes predictions consistent
with all six perturbation experiments; in particular, no model was able to explain the ‘DL
3 site’ and ‘ZLD sites’ perturbations simultaneously. To obtain a larger ensemble of models
similar to these twelve, we sampled 10000 points in the parameter space around each of the
12 models and optimized the parameters to fit the wild-type expression profile of ind, using
the sampled points for initialization. We retained from among the resulting models only
those whose predictions were consistent with the perturbation experiments by the above-
mentioned criterion. The retained models cluster into 18 different groups (as per method
noted in the next paragraph), and we sampled 100 models from each group to obtain an
ensemble of 1800 models in total. This collection of models is referred to as the “filtered
ensemble”. Systematic prediction of SNP effects using ensemble of models
We then followed the procedure in our previous work [42] to first cluster all models in
an ensemble and then construct a probability distribution over the models such that each
cluster (or group) of models has the same overall probability. We then computed the average
predicted effect of every possible single nucleotide mutations in the ind enhancer. The effect
of a mutation was computed by comparing a model’s predicted expression profile for the wild-
type enhancer to that for a mutated enhancer (carrying the specific mutation), and recording
the sum-of-squared-errors (SSE) between the two profiles. We repeated this procedure for
every model in the ensemble and computed the mean (as well as variance) of predicted
effects, over the above-mentioned probability distribution over the ensemble. Such ensemble
averages were separately computed for the wild-type ensemble, the filtered ensemble as well
as for each cluster of models within the latter.
3.3 STATISTICAL TESTING OF COMPENSATORY EFFECTS OF SNPS
We generated 2000 synthetic genotypes representing the ind enhancer that exhibit poly-
morphisms at the 70 SNP positions in the DGRP population, at the same allele frequencies
as in the population. For this, we first represented the DGRP genotypes as a genotype
matrix where the rows represent SNPs, columns represent lines and each cell in the matrix
is 0 or 1 depending if a line carries the SNP. We permuted this matrix while preserving the
sum of each row as well as each column. The permutation process selects at random two
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rows and two columns such that each row and each column of the resulting 2 x 2 matrix
has exactly one ‘0’ and one ‘1’, and swaps its rows, and the repeats this operation 1000
times. At the end, a column is chosen at random from the resulting permuted matrix and
represents a sampled genotype. For each sampled genotype, we made model-based predic-
tions of the effect (SSE) of all mutations present in that genotype as well as the effects of
each mutation individually, and deemed the genotype as exhibiting compensatory mutation
if the effect of all mutations together was less than the strongest among individual mutation
effects. We compared the number of genotypes with compensatory mutation (964 of 2000)
to the corresponding number in the DGRP (168 of 205), using a Fisher’s exact test.
In vivo reporter assays
ind1.4 enhancer constructs were prepared using as a template the wild-type version of
the enhancer present in DGRP line RAL-821. Mutagenized enhancers carrying changes at
positions 1198, 309 and 309 + 324 (“construct1”, “construct2”, “construct3” respectively, see
Results) were generated by recombinant PCR and sequenced to confirm their integrity. The
final transgenes were assembled in the placZ-attB vector [81] and integrated at chromosomal
position 86F via C31-mediated germ-line transformation [82].
3.3.1 Model Predictions for rho Enhancer
These models had eight parameters, four of which (KDL, αDL, KSNA, αSNA) were shared
with models for the ind enhancer and were kept fixed at values trained on the ind data,
while the other four (KTWI , αTWI , the cooperativity parameter ωDL−TWI , and qBTM) were
trained on rho data set of Sayal et al. [18].
3.4 EXPRESSION DATA SUPPORT DIVERSE MECHANISTIC MODELS OF IND
ENHANCER FUNCTION
Our first goal was to train a model capable of predicting the impact of enhancer sequence
changes on gene expression. For this, we considered various models in the literature that can
predict gene expression profile from an enhancer’s sequence and information about transcrip-
tion factor (TF) concentrations and their DNA binding preferences (motifs) [35, 31, 32, 18].
We chose to work with one such model, called GEMSTAT [36], which was previously re-
ported by us and successfully used to model several developmental enhancers of Drosophila
[20, 49]. GEMSTAT uses a statistical thermodynamics formulation to capture the molecular
interactions between TFs and DNA and their quantitative impact on transcription rate. It
uses two tunable biophysical parameters for each TF: one parameter that represents acti-
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vation/repression strength and the other related to DNA-binding strength of the TF at its
optimal site. It has one additional global parameter corresponding to the basal transcrip-
tional machinery and optional parameters for cooperativity between specific pairs of TFs.
GEMSTAT uses available data – enhancer sequence(s), expression levels, TF concentrations
and TF binding specificities or ‘motifs’ – to find optimal values for its free parameters (usu-
ally 10-20 parameters, representing 5-10 TFs), and in some cases this procedure is known
to result in locally but not globally optimal parameter values. We addressed this prob-
lem in recent work [42] by generating and reasoning with an ensemble of model parameters
that fit the data, rather than determining a single parameter setting that maximizes the
‘goodness-of-fit’.
In the current work, we first modeled the expression data available for the ‘intermediate
neuroblasts defective’ (ind) gene in Drosophila melanogaster, following our previous work
[42]. The enhancer for ind is well characterized, and its regulators are well-studied. There
are two activators: Dorsal (Dl) and Zelda (Zld) and three repressors: Snail (Sna), Ventral
neuroblasts defective (Vnd) and Capicua (Cic). The expression data includes the spatial
pattern of ind gene and its TFs in the blastoderm stage of embryonic development, as
a 1-dimensional profile along the dorso-ventral (D/V) axis (Figure 3.1 A). By optimizing
parameters of the GEMSTAT model through a comprehensive grid-search, we obtained an
ensemble (‘wild-type ensemble’, see Methods) of 5237 models that produce close fits to the
wild-type expression pattern (Figure 3.1 B). (Each model is a distinct setting of tunable
parameters, see Figure 3.1 C.) We next challenged the ensemble of models with published
data [20, 53, 54, 55, 56] on ind gene expression under various perturbation conditions such
as mutagenesis of one or more sites of a TF or knockout of a TF. Discarding models in
the ensemble whose predictions were inconsistent with results from two or more of these
six perturbation experiments, and performing deeper sampling and optimization around
the remaining models, we constructed a new ensemble of models, henceforth called the
‘filtered ensemble’ that reasonably capture ind expression in wild-type as well as perturbation
experiments (see Methods). Closer examination of the filtered ensemble and clustering of
the parameter vectors revealed multiple groups of models in the ensemble (Figure 3.1 D).
The existence of several distinct groups of models is also clear upon visual inspection of a
lower-dimensional projection of the parameter vectors using principal components analysis
(Figure 3.1 E).
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Figure 3.1: Predictions and parameter values of “wild-type ensemble” and “filtered ensem-
ble” of models. (A) The expression profiles for TFs and the ‘ind’ gene are shown along the
Dorsal-ventral domain. The x-axis represents ventral (left) to dorsal (right) end of the D/V
axis and the y-axis is the expression value from no expression to the maximum observed
expression for each gene or TF, on a scale of 0 to 1. (B) Predicted ind expression (magenta)
from all models optimized to fit wild-type data (black). Each pink line shows the prediction
of a single model in the wild-type ensemble. (C) Parameter values of models shown in B.
Each row is a model in the ensemble and each column corresponds to a parameter, with
values scaled to the range of 0 to 1 across all models. The K parameter for all TFs and α
parameter of repressors are in logarithmic scale and the α parameter of activators, ωDl−Zld
and qBTM are in linear scale. (D) Similar to C, parameter values of “filtered ensemble” of
models, with sidebar colors denoting different groups of models that cluster together (see
panel E). (E) Two dimensional projection of 13-dimensional parameter space of the filtered
ensemble using the first two principal components. Colors are similar to sidebar in D.
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Figure 3.2: (A-F) Predictions of ind expression profile, made by models in filtered ensemble,
under six different perturbation conditions, compared to experimentally determined profile
under those conditions (green line) and wild-type ind expression (black line). Predicted
expression profiles are colored according to the cluster that the predicting model belongs to,
with colors being the same as those used in sidebar of panel D in figure 3.1. Experimental
data from the literature indicate that ind expression does not change when the strongest
predicted DL site in the enhancer is mutated (A), expands ventrally upon VND knockout
(B), but is not changed upon SNA knockout (C), and expands dorsally when two binding
sites of CIC are mutated (D). Also, peak ind expression is reduced by 65% when 3 DL sites in
the enhancer are mutated (E) and peak ind expression is reduced by half upon mutagenesis
of ZLD binding sites (F).
The predictions of each group of models in each of the perturbation conditions are shown
in Figures 3.2A-F, along with the true expression profiles in those conditions. We noted that
all groups of models were consistent with the four perturbation experiments represented by
Figures 3.2 A-F, and were additionally consistent with the experiments represented by either
Figure 3.2E or Figure 3.2F. Figure 1E reveals uncertainty about mechanisms underlying the
gene’s regulation, even after subjecting the model to data from the several experimental con-
ditions noted above. Each group or cluster of models represents a distinct hypothesis about
the regulatory mechanisms underlying ind regulation and further information is necessary to
narrow down the possible mechanisms. We looked to polymorphism data from a population
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of D. melanogaster lines [83] for such information, as described next.
3.5 MODEL-BASED ANALYSIS OF POLYMORPHISMS IN THE IND ENHANCER
We assessed all possible single nucleotide mutations in the ind enhancer (length 1416 bp,
Figure 3.3 A) using the filtered ensemble as follows: for every position in the enhancer, for
every possible mutation at that position, we predicted the effect of the specific mutation
using each model in the ensemble. We measured the magnitude of the predicted effect as
the ‘sum of the squared errors’ (SSE) between model-predicted expression profile of the wild-
type enhancer and predicted profile of the wild-type enhancer modified by that particular
mutation. We then summarized the effect (SSE) of the mutation as predicted by all models
in the ensemble, using a probability distribution over the filtered ensemble constructed as in
[42].
The predicted effect of a mutation is defined as the SSE averaged over the ensemble. Fig-
ure 2B shows these predicted effects for every position of the ind enhancer, aligned with the
position and strength of each TF binding site in the wild-type sequence (Figure 3.3A). (For
each position, only the mutation with greatest predicted effect is shown; see Supplementary
Figure A.7 A-B for examples of such effects.) Following the same procedure, we also com-
puted variance of the predicted effect among models in the ensemble (Figure 3.3 C). The
‘heatmaps’ in Figure 3.3D depict the effect of all possible mutations within three specific
transcription factor binding sites (TFBS) that are strong matches to their respective motifs
and harbor mutations with relatively large predicted effects. Most models in the filtered en-
semble predict that the gene expression should change significantly upon mutating at least
one position within these strong binding sites (Figure 3.3D). Predictions were not entirely
consistent among models though, and different models vary in predicted extent of change.
For instance, Supplementary Figures A.7 A, C reveal discrepancies among the predicted
effects of a mutation in a VND site, as predicted by different models in the ensemble. We
noted above examples of single nucleotide mutations that could potentially cause a large
change in gene expression, although one might expect the more impactful mutations to be
avoided in a population, given that our analysis focuses on an early developmental enhancer
[84].
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Figure 3.3: Model-based analysis of polymorphisms in the ind enhancer. (A) TF binding
sites in the ind enhancer. The x-axis shows positions in the enhancer (base-pairs) and the
y-axis shows the predicted binding strength of each TF. (B) Mean predicted effect of each
possible mutation in ind enhancer. At each position of the enhancer, we introduce a single
mutation (one of three possible changes) and compute the SSE score between the wild-type
ind expression profile and the mutant expression predicted by a model. We average the
predicted SSE score across all models in the ensemble and show the maximum SSE score
among the three possible changes. (C) Similar to part B, but in place of average SSE over
models, y-axis shows standard deviation of the SSE score across models. As in B, only the
maximum over the three possible changes of the base pair at each position is shown. Stars
indicate locations of three binding sites for which predicted effects are examined in detail in
the panel below. (D) Heatmaps show the mean SSE score for each possible mutation located
inside three selected binding sites. (We selected three enhancer positions with the highest
mean SSE and located within binding sites of three different TFs; their encompassing sites
are selected for this display.)
We compared these impactful mutations to the allele frequencies of SNPs recorded in
a population of 205 lines, as per the Drosophila Genome Reference Panel (DGRP), and
noted that these mutations are indeed absent from this population. To further explore the
relationship between predicted functional impact and allele frequencies, we examined the 70
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Figure 3.4: (A) Mean SSE scores representing predicted effects of polymorphisms in DGRP.
The reference allele is denoted by the sequence at the top and the observed alternative
allele is indicated by a black-bordered cell. Red asterisks indicate positions located within
TF binding sites in the wild-type enhancer sequence. Positions outside such sites may
also have predicted effects, if the alternative allele results in the creation of a site. (B)
Distribution (across all models in ensemble) of SSE scores representing model-predicted effect
of a polymorphism, for each DGRP SNP. (Only SNPs where at least one model predicts a
non-zero effect are included.) Each boxplot shows one such SNP and color indicates the
TF whose binding site harbors the SNP. Each black dot is the average SSE score of one
cluster of models (from Figure 3.1 D). (C) Each black dot in the scatter plot represents an
individual (strain) in the DGRP, x-axis is the highest predicted effect (SSE) of any single
polymorphism in the individual, and the y-axis is the predicted effect of all polymorphisms
in the individual, taken together. (Predicted effects shown are the mean across all models
in ensemble.) Dots of larger sizes represent genotypes with greater frequency in the DGRP.
The black line represents the y=x. The plot suggests that most individual enhancers have
their largest-effect SNP compensated by other SNPs within the enhancer.
40
positions in the 1416 bp-long ind enhancer that are polymorphic in the DGRP population
(Figure 3.4A). Eleven of the 70 SNPs fall within the annotated binding sites (marked by
‘*’ in Figure 3.4A), and another 7 SNPs give rise to new weak binding sites. In total, 18
of the 70 SNPs may cause changes to binding site strengths and thus to ind expression
(Supplementary Figure A.8 E). We used the filtered ensemble to predict the effect of each
of the 18 SNP positions separately (Figure 2F and Supplementary Figure A.7 E), and noted
that the maximum of these predicted effects – SSE of 0.15 for position 309 – is relatively
small compared to the largest predicted effect (SSE of 0.35 for position 1198, Figure 2D and
Supplementary Figures A.7 A-C) among all possible mutations, suggesting that high impact
mutations are avoided in the population, as expected.
Figure 3.4B and Supplementary Figure A.7 D also reveal that for several of these 18 SNP
positions different models in the ensemble make mutually inconsistent predictions (high
versus low effect). Such variance in predicted effects points to ambiguities in underlying
mechanisms, and offers candidates for experimental testing: data on the true impact of a
SNP with ambiguous effect should help constrain the filtered ensemble further and narrow
down the viable groups of models further.
3.5.1 Evidence of Compensatory Mutations in Individual Enhancers
Each line in the DGRP population may manifest zero, one or more of the above 18 SNPs,
and the net effect of multiple alternative alleles present in a line may not be the sum of
their individual effects, i.e., there may be compensatory effects from multiple mutations in
an individual enhancer. To investigate this, we next used the filtered ensemble to predict
the expression profile of each line’s enhancer-level genotype and compared the effect (SSE
between this prediction and wild-type expression) to the largest effect from a single mutation
carried by the line (Figure 3.2 G). We noted that a great majority (82 %) of lines exhibited
signs of compensatory mutations (points below the y=x line in Figure 3.2 G), and that
almost all lines were predicted to have an ind expression profile very similar to the wild-
type profile (Supplementary Figure A.8 A). We also generated a large number of synthetic
genotypes (see Methods) that harbor zero, one or more of the 18 SNPs while preserving
allele frequencies of each SNP, and repeated the above exercise (Supplementary Figure A.8
B-D) to obtain a null distribution of the compensatory effect. The fraction of lines that
exhibit compensatory mutations in the real population (82%, as noted above) was found to
be significantly higher than that in the empirically estimated null distribution (52%) (p-value
¡ 9.62 *10E-22), substantiating the observation of compensatory mutations within lines.
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3.6 EXPERIMENTAL TESTING OF SELECTED POLYMORPHISMS IDENTIFIES A
SINGLE MECHANISM
We identified (above) several single-nucleotide mutations, present in the population or
otherwise, for which the filtered ensemble predicts a large average effect on ind expression
or exhibits a high degree of uncertainty. We used in vivo reporter assays to test the expres-
sion pattern driven by three such variants (called “construct1”, “construct2”, “construct3”
repecively and explained belo) of the ind enhancer.
The first experiment (“construct1”) was designed to test the single mutation that has the
greatest predicted effect, averaged over the ensemble. This mutation (Figure 3.5 A), a T -¿
G change at position 1198 in the enhancer, impacts a crucial residue in a high affinity VND
binding site, which might result in ventral de-repression of the enhancer, i.e., in its ventral
border expanding. The mutation is not seen in the DGRP population, but was selected for
the high average and moderate variance in predicted effect. In particular, while the mean
prediction of the ensemble of models was a significant ventral de-repression, a subgroup of
models in the ensemble also predicted no change in expression, indicating ambiguity in the
ensemble.
The second experiment (“construct2”) was designed to test a mutation with a high un-
certainty, i.e., large variance among predicted effects from different groups of models. This
variant (Figure 3.5 B), an A −→ C change at position 309 in the enhancer, is predicted to
reduce the binding strengths of two overlapping binding sites of the activator DL. The pre-
dicted impact of this mutation, which is seen in 6.1% of the DGRP lines, is a 25% reduction
in the peak height (maximum expression level) on average, but there are groups of models
that predict over 50% reduction and those that predict almost no change in expression. In-
terestingly, the same group of models (cluster 16, Figures 3.3 A,B) predicted the smallest
change for both of these enhancer variants.
The third construct (“construct3”) tested harbors two single nucleotide differences from
the wild-type, and was predicted unanimously by all models in the ensemble to have no effect
(Figure 3.5D). The two variants, which are present together in six DGRP lines, include the
A −→ C change at position 309, introduced in the previous paragraph, that should decrease
DL binding strength, and another mutation, a T −→ A change at position 324, also located
within a DL binding site and predicted to increase DL binding strength. Together these
two changes are predicted by several groups of models to compensate each other, while
at least one group predicts neither to impact expression (see Supplementary Figure A.9).
We tested the three above variants of the ind enhancer, as well as the wild-type enhancer,
through reporter transgenic embryos and confocal laser scanning microscopy (Figure 3.5E,
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Figure 3.5: Selection and in vivo testing of polymorphisms. (A-D) Model-based predictions
of ind expression profile driven by four different variants of the wild-type ind enhancer,
each variant differing from the wild-type in either one position (A-C) or two positions (D).
Predicted profiles from each cluster of models in the ensemble are averaged and shown
separately, in a cluster-specific color. In each panel, inset shows the mutated position in
the context of the binding site harboring that position and the motif of the corresponding
TF. (A) The selected mutation is located at a key position within a perfect VND site but
is not observed in the DGRP population. (B) This DGRP SNP is located within two
weak DL binding sites that are conserved across Drosophila species. Multiple groups of
models predict a large impact for the mutations shown in A and B. (C) The mutation
shown affects a position located within a DL binding site, but the position has a “T’ in
the wild-type enhancer in place of the preferred “A” (according to the motif); most models
predict a modest increase of expression due to a T-¿A mutation at this position, which
results from the increased (predicted) binding site strength. (D) Model-based predictions
of an enhancer carrying mutations at positions 309 (panel B) as well as position 324 (panel
C) of the enhancer suggest that these two mutations have compensatory effects. This pair
of mutations is seen in a subset of DGRP individuals (strains). (E) Embryos from flies
expressing lacZ under the control of either WT or variant enhancers (carrying mutations
shown in panels A,B or D) stained with probes for lacZ mRNA (red) and DAPI (cyan).
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see Methods for details). All three variant enhancers were found to recapitulate the wild-
type expression pattern of ind. There is exactly one group of models among 18 distinct
groups in the filtered ensemble whose predictions are consistent with these new experimental
data (Supplementary figure A.10 A-I). In other words, tests of three carefully chosen variant
enhancers allowed us to dramatically reduce the space of mechanistic explanations (see Figure
3.1E) to that represented by a tightly clustered group of models, ostensibly representing a
single mechanistic explanation of ind regulation. We refer to this group of models as the
“final ensemble”.
3.7 FINAL ENSEMBLE PREDICTS THE GENE EXPRESSION IN ORTHOLOGOUS
ENHANCERS AND VARIANTS OF RHOMBOID ENHANCER
3.7.1 Final Ensemble is Consistent with Orthologous Enhancers
Orthologs of the D. melanogaster ind enhancer from other Drosophila species are expected
to drive similar expression patterns, given the key role played by this gene in early embryonic
development. Under this assumption (also made elsewhere, e.g., [85, 86, 87]), orthologs
provide an opportunity to cross-validate models of enhancer function: accurate models when
applied to an ortholog may be reasonably expected to predict an expression pattern similar
to the known D. melanogaster pattern. We therefore predicted the expression pattern driven
by 10 different orthologs of the D. melanogaster enhancer, using the final ensemble alone or
using every group of models in the filtered ensemble (Figure 3.5). We noted that the final
ensemble makes accurate predictions for the majority of orthologs (Figure 3.6 B, D, F, H, L,
N), and provides more accurate predictions on the entire collection of orthologs, compared
to other groups of models (Figure 4U. For instance, for the most diverged ortholog – that
from D. mojavensis – the final ensemble is the only group of models that predicts expression
in the correct location (Figure 3.6 S, T).
3.7.2 Final Ensemble Makes Accurate Predictions on Variants of rhomboid Enhancer
In another attempt to test if the final ensemble is more accurate compared to other groups
of models in the filtered ensemble, we compared its predictions on the wild-type enhancer of
a different neuroectodermal gene, rhomboid (rho). The rho gene has an expression pattern
similar to that of the ind gene and its enhancer is well studied; in fact, Sayal et al. [18]
experimentally characterized the expression pattern driven by this enhancer as well as 37
synthetic variants thereof. Since the ind enhancer (subject of our modeling above) and the
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Figure 3.6: Cross validation of models on orthologs of ind enhancer. (A-T) For each or-
thologous enhancer sequence, we predicted the expression profile using models trained on
D. melanogaster. Predicted expression profiles from models in each cluster of the ensemble
were averaged and are shown by a line in a cluster-specific cluster. Averaged predictions
from the cluster known as the final ensemble are separately shown in panels in the second
and fourth columns (magenta). Orthologs were taken from D. simulans (A,B), D. sechellia
(C,D), D. yakuba (E,F), D. erecta (G,H), D. ananassae (I,J), D. pseudoobscura (K,L), D.
persimilis (M,N), D. virilis (O,P), D. grimshawi (Q,R), D. mojavensis (S,T). We observe that
for orthologs in D. mojavensis and D. virilis, two of the most distantly related enhancers,
the final ensemble (magenta) predicts expression in the correct position along the D/V axis
(same as in D. melanogaster) while other groups of models misplace the peak of expression
(for D. mojavensis) or predict no expression (D. virilis). (U) Mean RMSE (“root mean
squared error”) between wild-type ind expression and the expression profile predicted for
the orthologous enhancer from each species, for each cluster of models. We noted that the
mean RMSE for the final ensemble (magenta dots) is at the lower end of the distribution for
each species.
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Figure 3.7: Cross validation on rho enhancers. We used models of ind data as starting points
to train models for the wild-type rho enhancer. Four of the model parameters represent TFs
relevant to both ind and rho and were kept fixed at values trained on ind data; four additional
parameters were defined exclusively for modeling rho and needed to be trained. Models in
eight of the 18 ensembles in the filtered ensemble for ind data were incompatible with rho
data, and all models in the newly trained ensemble for rho data corresponded to (shared
parameter values with) the remaining 10 clusters in the ind ensemble, including the “final
ensemble”. (A) Distributions of values learned for the four new parameters are shown as box
plots, where each dot represents the average parameter value of models in a specific cluster.
(The points are colored by cluster.) (B) Expression profile of wild-type rho enhancer as
predicted by the models. The average predicted profile from models in each cluster is shown
individually, in cluster-specific colors, with the magenta line representing prediction by the
“final ensemble” (cluster 16).
rho enhancer have similar expression patterns (outputs) and share regulators (inputs), we
sought to cross-validate our models, trained with ind data, on the rho enhancer and its
variants [18].
The rho enhancer is known to be controlled by two activators – DL and TWI – and
one repressor, SNA. While DL and SNA were among the TFs included in the models of
ind above, TWI was not, and as a result the trained models are not capable of predicting
rho expression. To address this, we performed partial optimization of parameters on the
rho data set (37 synthetic constructs) from Sayal et al [18]. In particular, we considered
each model trained on ind data (previous sections), utilized the trained values of four of its
parameters that are shared between ind and rho models without further modification, but
trained four additional parameters unique to rho on the rho data set (see Methods). As a
result, each model in the filtered ensemble from above gives rise to a model for the rho data,
with four unchanged parameters and four newly trained parameters (Figure 3.7 A). The
accuracy of the resulting model on each of the rho enhancers (wild type and its variants)
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Figure 3.8: (A) Average expression in the bins near the peak of the rho expression profile
along the D/V axis (bins 8-12). The x-axis is the average expression from experimental
data and the y-axis is the model-predicted average expression in this domain. Each dot is
a construct (wild-type rho enhancer or variant thereof) in the dataset. Each panel is the
from a separate cluster of models, points being in a cluster-specific color (same as panel
B). The top left panel represents the final ensemble. (B) Similar to C, but the average
expression represents the ventral-most five bins (bins 1 to 5). The y-axis is the model-
predicted expression (average in this domain) and the x-axis represents the experimental
data.
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was then assessed using SSE score. We noted that not all models in the filtered ensemble
led to models capable of explaining the rho data set; rather, only models belonging to 10 of
the 18 groups of models in the ensemble could, upon training of the additional parameters,
provide fits better than a modest threshold of SSE = 0.1. The prediction of each of these
10 groups of models for the wild-type rho enhancer is shown in Figure 3.7B.
We next examined predictions of the above models on 26 enhancers that differed from
the wild-type rho enhancer in that the peak expression driven by these variant enhancers
is significantly lower than that of the wild-type enhancer (Supplementary Figure A.11).
We assessed how well the models in each group from the filtered ensemble capture this
phenomenon: for each group of models we computed the average predicted expression in the
peak expression region and compared it to the true (experimentally measured) expression
in that region (Figure 3.8 A). It was visually clear that models from the final ensemble (top
left panel in Figure 3.8 A) captured the reduced peak expression levels of these 26 variant
enhancers better than all other groups of models of the filtered ensemble. We similarly
examined predictions on the 9 enhancers that differ from the rho enhancer in a clear de-
repression in the ventral-most region of the embryo (Supplementary Figure A.12). For these
enhancers, we computed the predicted expression, from each group of models, in this spatial
region and compared it to the experimentally observed expression in the region (Figure 3.8
B). Visual inspection reveals that the models originating in the final ensemble capture the
phenomenon of ventral derepression better than six of the other groups of models and at
least as well as the remaining three groups in the filtered ensemble. In summary, the final
ensemble identified above based on our experimental assessment of mutation effects proved to
be far more accurate than competing groups of models, in terms of its ability to generalize
to a new data set comprising a related but distinct enhancer (the rho enhancer) and its
variants.
3.8 DISCUSSION
A major open problem today is how DNA sequence variations, e.g., single-nucleotide poly-
morphisms (SNPs), lead to phenotypic differences among individuals. A popular approach
is to find polymorphisms that are statistically correlated with the phenotype, as in genome-
wide association studies (GWAS) [5], family-based association tests [88], and expression
quantitative trait loci (eQTLs) [89, 90] for phenotype-related genes. However, statistically
identified variations may not be functionally related to phenotypes [91], due to a variety of
factors including linkage disequilibrium (LD) and redundancy of genetic systems. This prob-
lem is particularly pronounced in the case of non-coding variations, which form the majority
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of GWAS findings [4] and function by influencing gene regulation. Accurate contextual or
mechanistic information about non-coding variations can help us pinpoint those that are
causally related to the phenotype [80, 6]. The work presented here is a step in this direction,
and provides an example of how detailed mechanistic models of the sequence-to-expression
relationship encoded by an enhancer may help us predict the effects of non-coding variations.
This in turn can lead to better prioritization of phenotype-related variants and also provide
mechanistic explanation of their effects.
In recent years, various machine learning-based methods such as gkm-SVM [28] and
DeepSEA [27] have been proposed for modeling the sequence-function relationship encoded
throughout the non-coding genome. These have been successful in predicting the impact
of variants on epigenomic states such as DNA accessibility and TF-DNA binding [28, 27],
although some reports indicate there is significant room for improvement in their accuracy
[92] There is also evidence that these machine learning methods can help identify eQTLs
and disease-related variations. The thermodynamics-based modeling approach used in our
work offers a complementary approach to variant interpretation, and while it is far less scal-
able than the ML-based methods it is more mechanistically grounded and potentially more
precise. It is also possible that similar models, once trained on high throughput data such
as those from massively parallel reporter assays [93], will provide mechanistic predictions
about non-coding variations on a larger scale than the current work. In a simple illustration
of how mechanistic models can be useful at scale, Xie et al. [94] showed that motif-based
biophysics-inspired models of TF-DNA binding predict SNPs that likely impact binding
strength and lead to inter-individual variation in chemosensitivity.
The use of mechanistic quantitative models to examine polymorphisms, though uncom-
mon today, is not entirely new. Gursky et al. [21] analyzed polymorphisms in Drosophila
strains (the same collection as in our study) using the same sequence-to-expression model.
They reported several valuable insights, including additive effect of multiple polymorphisms
in individual genotypes and evidence of selective pressure at the level of combinations of
SNPs. Our analysis has conceptual and methodological similarities to Gursky et al., with a
few key differences. First, our approach recognizes that uncertainties in the model (values
of parameters) can lead to ambiguities in polymorphism analysis, and our predictions are
accompanied by estimates of the resulting uncertainty. More importantly, while Gursky
et al. focused primarily using the sequence-to-expression model to reveal insights about
a collection of polymorphisms, we focus more on functional analysis and use experimental
assays of variant effects to refine the models, making them more precise and more ready for
future applications. Our work also underscores the value of model-based design of biological
experiments. Two of the three enhancer variants that we tested were chosen because models
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based on prior data were ambiguous in their predictions regarding those variants. After we
performed those experiments, the results led to a significant narrowing of the feasible models
and this smaller feasible group of models was then shown to be more consistent with held-
out data sets (based on orthologs of the ind enhancer as well as several synthetic variants
of the rho enhancer) than the original broader ensemble of models. We hope that such iter-
ative applications of modeling and experimental testing, with models furnishing candidates
for experimentation and experimental results refining the models, will be more frequently
adopted in future investigations.
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CHAPTER 4: TISSUE SPECIFIC ANALYSIS OF NON-CODING
VARIATIONS
4.1 STUDYING GENETIC VARIATIONS IN THE NON-CODING DNA
Analyzing genetic variants in the genome is appealing as it can unveil not only the genetic
basis of disease, but in studying interpersonal genetic variation, imparts knowledge as to how
SNPs and other genetic variations exacerbate the fractional risk of developing that disease.
For instance, the neuro-degenerative disease dementia is not wholly inherited, but is partly
influenced by variation associated with the particular SNPs a person has inherited [95].
Identifying genetic variants with functional impacts is thus essential to advancing precision
medicine tailored to individuals. The most challenging task in studying genetic variation
lies in assessing their functional impact on direct molecular interactions and the manner
in which these effects cascade to influence systemic cellular and organismal processes.[96].
One particular cellular process that genetic variants have clear and significant influence
over is gene regulation, the phenomena in which the protein products of one gene bind to
preferred DNA sequences proximal to a target gene in order to attenuate the kinetics of the
transcriptional expression of the target). The composition and distribution of these preferred
DNA sequences (binding sites) of a given transcriptional regulatory factor (TF) can be
disrupted by alterations in the TF binding sites (TFBS). Understanding the mechanisms and
underlying logic governing gene regulation thus, is critical to interpret the exact consequence
of genetic variants on such an instrumental cellular process.
Unlike the process of DNA replication or transcription itself, the biology of gene reg-
ulation is far from completely understood; further compounding the problem is that the
one known characteristic of this phenomena, that regulators bind in noncoding regions of
DNA, is accompanied by the fact that the majority of inherited SNPs lie in the non-coding
regions which harbor the regulatory elements. Though such SNPs can disrupt the effec-
tiveness of TFBS, the overlapping of SNPs within TFBS is not sufficient to conclude a
regulatory effect, making TFBS as a functional filter much more difficult to wield than say
non-synonymous coding SNPs [97]. The consequences of sequence variation depend on a
litany of circumstances, including the tissue in which the gene is functional, the regulatory
network or functional pathways in which the gene is involved, the organism developmental
stage, the exact base pair and position in the TFBS the SNP interrupts, the behavior of
other regulatory factors, the precise logic of the regulation between a TF and target gene,
among countless other complicating variables. [7, 17, 16]. Even concentrating on this inter-
preting genetic variation in the context of this particular biological process incurs significant
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complication. Nevertheless, researchers have developed statistical and mathematical models
to, piece by piece, uncover the causal links between the DNA variations and gene expression
levels in individuals [96, 6, 17].
Genome-wide association studies (GWAS) have identified thousands of single-nucleotide
variants associated with complex traits or diseases [98, 99]; however, the functional impact
of these variants and their connections to disease etiology remain elusive. GWAS, and
association methods in general that try to implicate genetic variants in isolation of one
another, run into problems with linkage disequilibrium (LD), a phenomena in which proximal
genetic variants are likely to covary; because SNPs close to one another correlate, correlation
based methods like GWAS that implicate one SNP in an LD block tend to implicate them
all, which means the strength of the statistical association is insufficient to infer a biological
mechanism without additional context.
The genetic variants that underlie the phenotype are more likely to be associated with the
gene expression (i.e. expression quantitative trait loci (eQTL)) [100, 101, 102]. One major
issue in these studies is that some may not be causal although studies find them signifi-
cant. Modeling the entire system of biological entities and their relations is computationally
prohibitive and data intensive and so elucidating the set of transcriptional regulatory depen-
dencies among genes presents a feasible and yet powerful alternative to identify the cellular
processes pertinent to disease biology. One of the simplest and most common methods for
constructing GRNs relies on a general technique called co-expression analysis [103, 104, 105],
which identifies clusters of genes that covary and, from these clusters, uses regression anal-
yses to infer where clusters of genes are identified on the basis of similarities in expression
profiles across samples; from these clusters, regression analyses can help infer network topol-
ogy, where the nodes of the network correspond to genes and directed edges, from say gene
A to gene B, imply gene A regulates the expression of gene B. Such co-expression pro-
cedures suffer from myriad problems when not supplemented with additional information.
For instance, co-expression analyses omit much of the underlying biology of transcriptional
regulation, assuming that correlated gene expression is proof of a regulatory relationship.
However, this need not be true as other factors can account for co-expression, such as cel-
lular perturbations and cell cycle. In cases where these are well controlled, straight forward
co-expression methods produce convolved network structures that disregard the sequence of
regulation; for example, if gene A regulates B which regulates C, convolved networks suggest
that gene A directly regulates gene C. Network deconvolution methods are then required
to infer the real GRN network structure from its noisy reconstruction, often through latent
variable analyses [106]. Such methods though have their own limitations and recent research
[107].
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A staple of regulatory biology is that regulators bind in proximity to the genes they
regulate and in doing so, change the kinetics of transcription to influence the target gene’s
expression. By not taking into consideration the distribution and strength of TF binding sites
near target genes, co-expression derived GRNs fall prey to false positives (i.e. illegitimate
TF → target gene links) as they may be missing the needed biology for the TF to exert
its influence. This is but one of many ways in which coexpression itself is insufficient for
accurate GRN reconstruction. We employed a probabilistic graphical model to construct
a gene regulatory network and find mutations that mediate the effect of gene expression
variation across individuals. We used GTEx data [108] to build a tissue specific regulatory
network and predict the mutations that causally influence the gene expression levels through
changing binding sites of relevant TFs. To our knowledge, this represents the first such
approach to combine the knowledge of TF binding and the single nucleotide variations
associated with the gene expression changes (eQTL SNPs) as regulatory evidence to de
novo construct transcriptional regulatory networks specific to the tissue.
4.2 ANALYSIS OF SNPS LEVERAGING GENE REGULATORY EVIDENCE
Gene regulatory network can control which genes are expressed and the extent of gene
expression levels. There are many factors that can decide the transcription of the genes and
the protein products, such as transcription factors and other protein products [109, 110].
Understanding the role of gene regulatory network is the fundamental step in shaping a
mechanistic view and interpreting the effect of genetic variations. Variation in gene expres-
sion levels is co-related with changes in the phenotype and the disease state. Transcription
factors (TFs) regulate gene expression levels and perturbations in the binding sites for the
TFs that regulate the gene may cause a change in the gene expression. Minor changes
such as a single nucleotide change in the DNA can potentially affect the gene regulatory
mechanisms.
Assumptions of the model:
• The TF regulates certain genes to influence the phenotype
• TF does not change its role as an activator or a repressor in a given tissue
• Perturbing the relationship (e.g., by changing the strength of the binding site) should
impact expression of the genes targeted by the TF
The eQTL data provides information on the variants that associate with the expression
changes (figure 4.1 A). We use the GRN to assess how regulatory processes might be per-
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Figure 4.1: Relationship between gene expression and genotype These panels are
schematic diagrams of gene expression variations across different individuals. Assuming we
have mRNA levels of a given gene for many individuals and a SNP position where there is
a difference between gene expression levels of individuals carrying the SNP. A) The eQTL
analysis finds SNPs with significant associations. The y-axis is the gene expression level and
the x-axis is the genotype. Each point on the scatter plot represents gene expression level of
one individual. B) The x-axis represents the change in binding strength of the transcription
factors at the location of the SNP. TF1 has smaller change in the TFBS than the TF2
but they play the same role in regulating the gene. TF1 and TF2 act as a repressor since
increasing the binding strength of the TF decreases the gene expression levels. TF3 does
not have an effect and TF4 plays the opposite role (activator) in the gene regulation.
turbed and determine the role of SNPs in this process. From the GRN, we can determine if
the TF targets the gene and the GRN can be constructed using the data from the strength
of the binding sites of the TF and the significance of the eQTL p-values. If the TF that
targets the gene is an activator, increasing the transcription factor binding strength (TFBS)
increases the gene expression levels and decreasing the TFBS decreases the expression levels
(figure 4.1 B).
In this work, we provide a simple statistical framework for associating transcriptional
mechanisms with gene expression variations across different individuals. The algorithm
proposes that certain SNPs mediate the effect of transcription factors on gene expression
variations. More specifically, we assume the effect is mediated through the SNPs that are
within 100 Kbp of transcription start sites of gene’s and their presence correlates with the
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Figure 4.2: Diagram of data Single Nucleotide Polymorphisms (SNPs) are depicted by
white or black dots depending on the allele. The gene expression levels are shown as the
green squiggles. For a given TF, the strength of the binding is measure by the yellow peaks.
The green diamonds depict the positions of the eQTLs and the green horizontal lines are
the functional positions of the genome.
expression variations of the genes (eQTL SNPs) and change the binding sites of associated
TFs. While these signals can be noisy in gene levels, aggregating them through different
targets genome wide allows the true signal to be detected. In this manner, we can interpret
SNPs in a cis-regulatory context and link them to genes in a biologically meaningful manner.
The following is the model we propose for this study. We use motifs to scan the DNA
positions with the genetic mutation reported in the original data. We use a score that
reflects the amount of change in the TFBS due to the genetic mutation. We represented
a schematic of the data that the model aggregates in figure 4.2. The change in TFBS is
depicted in yellow, the eQTL SNPs are shown with green diamonds. The functional locations
are highlighted by vertical green lines.
4.2.1 Data Collection
In this study, we combined several pieces of information from different studies to define
the genotype- phenotype relationship: (1) The List of genes for which significant eQTLs are
available from GTEx data; (2) CIS- BP dataset of DNA binding specificity for about 700
different TFs [111]; and The goal of the Genotype-tissue expression (GTEx) project is to
estimate how the genetic variants change the gene expression in different tissues [112, 113].
The data is collected from 485 human donors across 48 tissues and the expression is measured
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Figure 4.3: GTEx eQTL variants and gene for 48 different tissues A) Bar plot of
the number of unique eQTL SNPs for each tissue. B)Bbar plot of number of unique eQTL
genes for each tissue
for every transcript in the samples (˜55,000 transcriptome)(Figure 4.3). We take the SNP
positions for each tissue and we scan the location of the genome with the reference allele and
the alternative allele [114]. Each motif is a position weight matrix (PWM) that specifies the
preference of TF to bind to the DNA. We use 1841 experimentally confirmed PWMs for 700
different transcription factors from the CIS-BP dataset [105, 104].
4.3 A PROBABILISTIC MODEL TO INTEGRATE REGULATORY EVIDENCE
WITH EXPRESSION QUANTITATIVE TRAIT LOCUS
The data from the Genotype-Tissue Expression (GTEx) project provides a large set of
SNP-gene associations identified via expression quantitative trait loci (eQTL) analysis - a
procedure that fractionally attributes the genetic variance of a gene’s expression to some
loci [115], often a single SNP (called an eQTL SNP if its eQTL analysis is sufficiently
statistically significant). The multicollinearity of SNPs proximal to a gene make it impossible
to disambiguate which SNP may be functionally responsible for the observed variance in gene
expression, and thus insufficient as a basis to infer causality.
Our goal was to address this issue by developing a principled method that could identify
the functional SNPs for a gene by examining, simultaneously, all eQTL SNPs for a gene and
56
their strengths of eQTL association. To aid in this pursuit, we supplemented the eQTL data
with ancillary data on the regulatory impact of each SNP on a TF’s binding to DNA (via the
TF’s motif). In doing so, we re-frame the aforementioned eQTL analysis around the biology
of transcription factors and transcriptional regulation. Consequently, the functional effects
we hope to elucidate observed correlations between genetic variation and gene expression
variation are regulatory in nature. Although we cannot promise to uniquely attribute a
single SNP to a gene’s expression, by conducting the analysis in a regulatory context, we
hope to significantly reduce the number of viable candidates.
After careful consideration, we elected to use probabilistic graphical models (PGMs) to
address this challenge - as such models provide a language to describe latent properties of
the data, such as the regulatory state of each SNP and TF, and tools to infer such states on
the basis of empirical evidence. In designing this PGM, shown in figure 4.4, we make the
following assumptions. The PGM we propose here considers a single TF model at a time.
For such a model, it is assumed that the TF regulates each gene independently, but that
the regulatory effect of a TF on a gene (activation/repression) is binary (true/false), latent,
and unknown at the time of inference. The model considers two branching paths depending
on if the TF regulates the gene. In cases where the TF regulates the gene, we expect the
p-value of the eQTL and p-value of the impact of the SNP on motif match strength to be
small for certain SNPs nearby the gene. However, in cases where the TF does not regulate
the gene, we expect our evidences to be independent of one another.
4.3.1 Overview
We evaluate the probabilistic model, described in figure 4.4, separately for each TF. The
model integrates different sources of regulatory evidence of the TF targeting the gene and
the SNP simultaneously disturbs the TF binding site and the gene’s expression. We rely
on regularly evidences of the TF regulating the gene, each weighted in accordance with its
contribution to the model, which combine in a probabilistic framework to determine the
probability the gene is a target of the TF and certain SNPs of the gene mediate the effect
of the TF on gene expression. In this analysis, we use two regulatory evidence: Motif scores
of the TF and from the GTEx data cis-eQTLs.
For each gene g in a tissue t, we get TFs indexed by T , such that there is an edge in
the GRN between TFT and gene g . For each pair of (TFT , g), the probabilistic graphical
model (PGM) determines if there is an edge between TFT and gene g and whether SNP
s nearby the gene g mediates the effect of T on the expression of g. Two hidden binary
variables Zg and Sig capture these relationships where Zg = 1 if T targets g and Sig = 1
57
Figure 4.4: Plate diagram for the PGM model. In this diagram, latent variable Zg
represents whether the TF targets a gene g and its enclosing rectangle denotes G such genes.
The latent variable Sig shows whether the SNP i associated with the gene g, mediates the
effect of the TF on the gene’s expression; and the rectangle represents Ng number of SNPs
for each gene g. If Zg = 1 and Sig = 1, we expect an enrichment for significant eQTL
p-values and significant changes in the LLR score of the motif. The joint distribution for
pmotif , peQTL is modeled by a beta distribution with parameter α < 1, β = 1; otherwise,the
model expects uniformly distributed p-values in [0,1] (Null hypothesis H0).
if the i’th SNP associated with the gene g mediates the effect of T on g. There are four




where pmotif,ig denotes the p-value of the motif score for the TF in a
window around the i SNP position of gene g and peQTL,igt is the eQTL p-value nominal from
the GTEx data for the tissue t at the i’th SNP of the gene g. There are 1.6 million motif
p-values and the number of eQTL p-values varies accross different tissues.
4.3.2 Detailed Description
N := Number of genes.
Ng := Number of SNPs within TFBS for gene.
peQTL,igt := The eQTL p-value for the i-th SNP and gene g in tissue t
σ := +1 if activator, -1 if repressor (set beforehand)
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Given all yig in tissue t as Y , we estimate the likelihood of Y as the following:










P (yig, Sig = k|Zg = j, q, α)× 1(Zg = j, Sig = k)
(4.1)
The 1(x) is the identity function where it evaluates to 1 if the statement x is true and
otherwise, it is 0.
Zg := A binary latent variable representing whether or not the correlation p-value of gene
g’s expression with the phenotype of interest is drawn from a uniform or beta distribution.
α := Parameter determining the shape of a beta distribution. The β parameter is set to
1 and α is capped in the range [0,1]. This parameter is estimated by the model.
pg := A continuous observed variable in the range [0,1] representing the correlation p-value
of gene g’s expression with the phenotype of interest obtained from the GTEx data.




P (Zg = 0|q)
Ng∏
i=1
×1(Zg = 0, Sig)
{
P (yig|Sig = 0, Zg = 0, q, α)× P (Sig = 0|Zg = 0, q, α)
+ P (yig|Sig = 1, Zg = 0, q, α)× P (Sig = 1|Zg = 0, q, α)
}
P (Zg = 1|q)
Ng∏
i=1
×1(Zg = 1, Sig)
{
P (yig|Sig = 0, Zg = 1, q, α)× P (Sig = 0|Zg = 1, q, α)





Figure 4.5: Diagram of integration
4.3.3 Likelihood
The probability that Zg = 1 is a Bernoulli function:
P (Zg = 1|q) = q (4.3)
The probability of Sig = 1 given that the TF regulates the gene is:
P (Sig = 1|Zg = 1) = p (4.4)
The probability of Sig = 1 given that the TF does not regulate the gene is:
P (Sig = 1|Zg = 0) = 0 (4.5)





C × αyigα−1 × yig if 0 ≤ yig ≤ 12C × αyigα−1 × (1− yig) 12 ≤ yig ≤ 1 (4.6)























































× (1− 2−α) (4.10)
If Sig = 0, then
Pnull(yig) = P (yig|Sig = 0) ≈ uniform (4.11)








Pnull(yig)× 1 + Palt(yig)× 0
}
+




Pnull(yig)× 1(Sig=0)(1− p) + 1(Sig = 1)× p× Palt(yig)
}]
(4.12)











Pnull(yig)× (1− p) + Palt(yig|α)× p
}]
(4.13)

















































































































Note that we can write x = elog (x) and log(
∏
xi) = Σi log(xi) The function logSumExp(x, y) =
log (ex + ey).
We can either optimize this function directly or use Expectation Maximization. In this
formulation, we choose EM. Then, we compare the log likelihood ratios between this model
and the null model to get a ranking of different transcription factors in each tissue.
4.3.4 Expectation Maximization


















P (Zg = 0, Sig = 0|yig, θt−1) logP (yig, Zg = 0, Sig = 0|θt) (4.21)
+ P (Zg = 0, Sig = 1|yig, θt−1) logP (yig, Zg = 0, Sig = 1|θt)
+ P (Zg = 1, Sig = 0|yig, θt−1) logP (yig, Zg = 1, Sig = 0|θt)











































Palt(yig|αt)× pt × qt
)
wt−100,ig =
P (Zg = 0, Sig = 0, yig|θt−1)
P (yig|θt−1)
=
Pnull(yig|α)× 1× (1− q)





(1− pq)Pnull(yig) + pq × Palt(yig)
(4.25)
wt−101,ig = 0 (4.26)
wt−110,ig =
(1− p)× q × Pnull(yig)




(1− pq)Pnull(yig) + pq × Palt(yig)
(4.28)





































) + wt−110,ig × (
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11,ig × log yig
(4.37)












































At each step, we update θt = θt−1 − λ×∇(Q) where θ = (α, q, p) and λ is learning rate.
αt = αt−1 − λ× ∂Q
∂α
qt = qt−1 − λ× ∂Q
∂q
pt = pt−1 − λ× ∂Q
∂p
4.3.5 Inference of the Hidden Parameters
The posterior probability of Zg is the following:
P (Zg = 1|yig, α, q, p) =
Ng∏
i=1
P (Zg = 1, yig|α, q, p)






k=0 P (Sig = k|Zg = 1)× P (yig|Sig = k)∑1
k=0
∑1
j=0 P (Zg = j|q)× P (Sig = k|Zg = j)× P (yig|Sig = k)
P (Zg = 1|yig, α, q, p) =
Ng∏
i=1
(1− p)qPnull(yig) + pqPalt(yig|α)
(1− pq)Pnull(yig) + pqPalt(yig|α)
(4.40)
P (Zg = 1|yig, α, q, p) =
Ng∏
i=1




P (Zg = 1|D)







P (D|Zg = 1)× P (Zg = 1)







P (Di|Zg = 1)
P (Di|Zg = 0)
≥ 1
66
P (Zg = 1|D)
P (Zg = 0|D)
=
P (D|Zg = 1)× P (Zg = 1)
P (D|Zg = 0)× P (Zg = 0)
=
P (Zg = 1)
P (Zg = 0)
Ng∏
i=1
P (yig|Zg = 1)





P (yig|Sig = 0)× P (Sig = 0|Zg = 1) + P (yig|Sig = 1)× P (Sig = 1|Zg = 1)





Pnull(yig)× (1− p) + Palt(yig|α)× p














P (Sig = 1|D)
P (Sig = 0|D)
=
P (D|Sig = 1)× P (Sig = 1)
P (D|Sig = 0)× P (Sig = 0)
(4.45)
The posterior probability of Sig = 1 is the following:
P (Sig = 1|yig, α, q, p) =
P (Sig = 1, yig|α, q, p)
P (yig|α, q, p)
=
P (yig|Sig = 1, α, q, p)× P (Sig = 1|α, p, q)∑1
k=0
∑1
j=0 P (yig, Sig = j, Zg = k|α, q, p)
(4.46)
We first calculate P (Sig = 1|α, p, q):
P (Sig = 1|α, p, q) =
1∑
j=0
P (Zg = j|q)× P (Sig = 1|Zg = j) (4.47)
Filling in:
P (Sig = 1) = p× q + 0× (1− q) = pq (4.48)
P (Sig = 0) = (1− p)× q + 1× (1− q) = 1− pq (4.49)
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P (Sig = 1|yig, α, q, p) =
P (Sig = 1, yig|α, q, p)




j=0 P (Zg = j|q)× P (Sig = 1|Zg = j)× P (Yig|Sig = 1)∑1
k=0
∑1
j=0 P (Zg = j|q)× P (Sig = k|Zg = j)× P (Yig|Sig = k)
=
pqPalt(yig)
pqPalt(yig|α) + (1− pq)Pnull(yig)
= w11,ig
P (Sig = 1|yig, α, q, p) = w11,ig (4.51)
P (Sig = 1|D)
















4.3.6 Log Likelihood Ratio
We estimate the parameters of the model using the above approach. Then, we compute
the log likelihood of the data given the parameters. For the null model, we set parameter
p = 0 or q = 0 or α = 1 and compute the differences in the log likelihood of the alternative
model compared to the null model as the following.
LLR = logP (y|A, H = 1)− logP (y|A, H = 0) (4.54)
We scan 100 Kbp upstream and 100 Kbp downstream of the transcription start site for the
gene g for to annotate binding sites for TF T . For each PWM for the TF T , we report the
difference in the LLR score at the positions around the location of the eQTL SNPs; LLR of
the reference and LLR of the alternative allele is computed using MOODS package in python
[116]. We threshold the LLR scores at zero since negative LLR for the motif indicates that
the TF has no binding sites at the location of the SNP. The ∆LLR for the motif is computed
as the difference between LLR reference and LLR of the alternative allele. The motif score
is reported for each TF binding site overlapping with the eQTL and we take the maximum
∆LLR score for each eQTL position. Since LLR depends on the length of the TFBS motif,
we normalize the scores by ranking the ∆LLRs and computing a cumulative distribution
function (CDF) based on the ranked values. For each eQTL position s, the p-value of the
∆LLR score is computed as 1 − CDF (s). The two p-values, one for the eQTL and one
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for the motif will be averaged to get y values. Then the PGM model is trained with the
y and we get an estimate of the parameters of the PGM model fitting the data (yig for all
SNPs i of the gene g. For each gene g, the direction of LLR change and the expression
change (reference vs alternative) carries information on the role of the TF in the regulation
of the gene. We compute the sign of ∆LLR × ∆Expr to infer the role of the TF. Here,
∆LLR = LLRref − LLRalt and ∆Expr = Exprref − Expralt where Exprs is the average
expression of the gene g for all individuals carrying SNP s.
In each tissue t, we estimate the likelihood of the PGM model using the trained parameters
from the data computed above. We also estimate the likelihood of the PGM under the null
model and compare the likelihood ratios for all PWM files of the TF T . There are multiple
PWM files for some TFs. We chose the PWM with the best likelihood ratio to represent
such TFs. Once we have the best PWM for all TFs, we order the TFs based on their best
likelihood ratios and take the top 20 TFs in each tissue. The union set of the SNPs where
there is an edge (Zg = 1) between any of the 20 TFs and gene g forms the important gene
set in the tissue t. We chose the functional SNPs from the SNPs that fall nearby the gene
set that comes out of the previous analysis conditioned on Sig = 1. Then we get a ranking




We also have a TensorFlow implementation available for download, although this imple-
mentation was not used to generate the results of this study.
4.3.8 Code Location
Both the python code used to generate the results of this chapter and the TensorFlow
code are available in a GitHub repository located at https://github.com/khajoue2/pgm
and with a link to the GitHub repository at veda.cs.uiuc.edu/pgm .
4.4 USING THE PROBABILISTIC GRAPHICAL MODELING TO PRIORITIZE SNPS
IN SIMULATED AND REAL DATA
4.4.1 Simulated Data
To evaluate the accuracy of our model, we applied the model on a simulated dataset. We
generated synthetic data for G = 500 genes, where there are Ng = 100 SNPs per gene.
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The data consists of eQTL p-values and motif score p-values for each SNP. These scores
are generated from either a uniform distribution or a beta distribution with parameters
(α = 0.2, β = 1) depending on the values of the hidden variables Zg and Sig.The hidden
variables are fixed based on the following assumptions: 10% of the genes are targeted by the
TF T (q, 0.1) and for each g that is a target of the T , 5% of the SNPs are mediating the
effect of T on expression of the gene g (parameter p = 0.05).
Figure 4.6: Simulation Parameter Estimation The EM algorithm converges to the true
parameters of the simulated data. Each dot shows an iteration of the EM and the red colored
points are the close points to the true parameters.
There are G× q = 50 genes with Zg = 1 and for each gene, Ng× p = 5 SNPs with Sig = 1
Given the simulated data, we estimate the parameters of the model and predict the hidden
values. We report the accuracy of the parameter estimation using the EM algorithm by
computing the true positive, false positive, true negative and false negative values. Figure
4.6 shows that the EM algorithm converges to the true parameters after several iterations.
We tested the sensitivity of the PGM to the parameter estimations.
It is important to know that the EM algorithm does not always converge to the true
parameters of the model since it is a local optimization method. To avoid that, we selected
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Figure 4.7: Sensitivity of the model to the parameter estimation Each panel shows
the ROC plot for a fixed alpha on the title. The colors in (A) correspond to the p parameters
and the colors in (B) corresponds to the q parameter.
1000 starting points for the EM algorithm and then the final converged parameters are
compared against each other. We select the top 10 parameters converged from the EM and
estimate an ensemble of models for the posterior probability of the SNPs. The posterior is
computed as the average posteriors of these 10 parameters and we take a union over the
SNPs that score highly from this ensemble.
4.4.2 Real Data
We processed the data for each tissue in the GTEx project separately (44 different tissues).
The transcription factors modeled here were selected based on the presence of experimentally
confirmed motifs for the TFs in CIS-BP dataset. For each transcription factor T in a tissue
t, we trained the PGM and evaluated the likelihood of data under the alternative model
and compared it to the likelihood of the data under the null model. GTEx set of eQTL are
reported at the p-value significance around 10−4 and it does not provide the distribution of
the whole data. To resolve that, we downloaded all association data from the GTEx project
and included the QTL SNPs in our analysis. We only included the QTL SNPs for which
the motif scores was computed; since the number of SNPs in the complete QTL data is
significantly larger and majority of these SNPs are not important in the final analysis.
For each TF T , we selected the motif with the best likelihood score of the data. Then we
sorted all TFs based on their likelihood ratios (alternative vs null) and selected the top 20
TFs. Then, we selected the genes that are the targets of these TFs based on the posterior
probabilities computed in equation 4.3.5 and 4.44. For every gene g that passes the threshold
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Figure 4.8: Validations A) We define the functional set of SNPs as the eQTL SNPs that
overlap with the H3K27ac marks. B) PGM model provides a ranking of the SNPs based on
the posterior probability ratios. We select the baseline as the eQTL SNPs ranked by their
p-values restricting one eQTL per gene. C) Hyper-geometric test of the significance
on P (Zg=1|Data)
P (Zg=0|Data) , we select the nearby SNP i that is associated with the gene g based on the
largest posterior
P (Sig=1|Data)
P (Sig=0|Data) . We get one SNP per gene from this ranking. Note that it is
possible that the same SNP ranks highest for two different genes since the SNP has large
motif score and the eQTL score was also large for more than one gene. The baseline method
to compare our results with is the following. We select one SNP per gene in the tissue based
on the eQTL p-value. Then we sort these SNPs from the strongest p-value to the smallest.
Then we take the top k SNPs from both this best eQTL method (baseline) and the PGM
method sorted by the posterior probability of the SNP (our method). We set k to be the
top 100 and top 1000 motifs.
We define a functional set of SNPs based on the overlap of the eQTL SNPs from GTEx data
and the H3K27ac marks from the ENCODE data [10] for the same tissue (figure 4.8).The
expected number of SNPs is calculated as k × #functionaleQTLs
#alleQTLs
. The predicted SNPs overlap
with the functional set of SNPs shows the power of our method compared to the baseline.
For a second validation, we defined the functional SNPs as the set of the eQTL SNPs
that overlap with the eRNA data in different cancer [117]. Then, we conducted a similar
enrichment test and reported the hyper-geometric p-values. We summarized the results
in the following tables for four different tissues (table A.4, A.5, A.6 and A.7). The PGM
method outperforms the baseline with the H3K27ac broad peaks. This chromatin mark
shows the active enhancer regions and it is expected to have multiple TF binding sites. The
H3K27ac narrow peaks does not show an improvement over the baseline but this is expected
since the narrow peaks mark the regions that are not necessarily bound by the TFs since
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the histones would occupy the DNA at the narrow peak locations. The number of overlaps
with the narrow peak in the baseline is consistent with the ratio of the width of the peak
from broad to narrow.
4.5 DISCUSSIONS
Ideally, we would like to link the whole genome sequence and use all variations to infer
such relations. We may report a SNP as causal in a disease, but it might be the case that
the actual causal variation could be another genetically linked but un-probed variant such
as an indel or a copy number variant. This means that those variants may be associated
with a different TF or a different gene. Another limitation in our study is using position
weight matrix of only 700 TFs (out of a total of 2000 known human TFs) since majority of
TFs are still devoid of DNA binding specificity. We can improve our result by a probabilistic
model that finds the SNPs that mediate the effect of the TF on the gene and can explain
gene expression variation across individuals. Using a probabilistic graphical model, we can
then compute the posterior probability that the variant mediates the TF’s influence on
expression. This model allows us to infer the role of the TF as an activator or a repressor.
Furthermore, this will allow us to use the information in the binding cite combined with the
gene expression sign (loss vs. gain of binding strength), not just its magnitude. We believe
that this approach allows us to understand the regulatory impact of a variant based on the
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APPENDIX A: SUPPLEMENTARY FIGURES AND TABLES
Figure A.1: The predicted ind expression from a wild-type ensemble of models and the
distribution of parameters in the ensemble. (A) The expression domain for TFs and the
‘ind’ gene is shown along the Dorsal-ventral domain. The x-axis represents ventral (left) to
dorsal (right) end of the D/V axis and the y-axis is the expression value from no expression
to the maximum observed expression for each gene or TD, on a scale of 0 to 1. (B) Predicted
average ind expression (magenta) from all models optimized to fit wild-type data (black).
Each pink line shows the prediction of a single model in the ensemble (C) Each row is a
model in the ensemble and each column corresponds to a parameter for the model. Each
parameter is scaled to the range of 0 to 1. The K parameter for all TFs and α parameter of
repressors are in logarithmic scale and the α parameter of activators, cooperativity and qBTM
are in linear scale. (D-F) Marginal densities of parameters of the ensemble. Each parameter
vector is scaled to be in the same range. The x-axes in (D) and (E) are in logarithmic scale
and in F in linear scale.
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Figure A.2: Filtered ensemble for each of six perturbation experiments in the literature.
The wild-type ensemble was filtered to retain only models that correctly predict the observed
effects of an additional perturbation experiment (A.1 Table), thus yielding a smaller, filtered
ensemble for each experiment. In each panel, wild-type ind expression is shown in black, pink
curves represent predictions of models in the ensemble and magenta represents a weighted
average of the ensemble predictions. (A) No change is observed in the expression when the
strongest DL site is mutated. (B) Peak ind expression is reduced by 65% after 3 DL sites are
mutated. (C) Peak ind expression is reduced by half upon mutations in ZLD binding sites.
(D) ind expression expands dorsally when two sites of CIC is mutated. (E) ind expression
expands ventrally in VND knockout. (F) The expression of ind is not changed in SNA
knockout experiment.
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Figure A.3: Selecting a ‘synthetic real’ model. We searched for a model that not only has a
good fit to the wild-type ind expression but also produces the known effects of perturbation
experiments reported in the literature (A.1 Table). Such a model would then be used as
the ‘truth’ for predicting the effects of other ‘experiments’. Starting from the wild-type
ensemble, we filtered models that predict the effect of CIC site mutation (‘CIC site Mut.’),
VND knockout (‘VND KO’), SNA knockout (‘SNA KO’) and mutagenesis of the strongest
predicted DL site (‘DL 1 site Mut.’) correctly, resulting in an ensemble of a few hundred
models. Then, we checked the ability of these models to reproduce the effect of an exper-
iment where three overlapping DL sites were mutagenized (‘DL 3 site Mut.’) and another
experiment where the four strongest ZLD sites were mutagenized (‘ZLD site mutation’). We
were unable to find any model that could reproduce both results correctly. Thus, we used
only one of these two filters to obtain an ensemble of models that can predict five out of six
perturbation experiments correctly. Shown are the predictions for the wild-type condition
and the six perturbation conditions, made by two distinct models, both of which fit wild-type
data and perturbation experiments ‘CIC site Mut.’, ‘VND KO’, ‘SNA KO’, ‘DL 1 site Mut.’
as well as either (A) ‘DL 3 site Mut.’ (this model fails to reproduce the effect of ‘ZLD site
Mut.’) or (B) ‘ZLD site Mut.’ (this model is unable to reproduce the effect of ‘DL 3 site
Mut.’).
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Figure A.4: Sensitivity plots for a model (MST) corresponding to A.3A Figure. (A-D) Panels
show the RMSE scores of the model as the corresponding parameter’s value is varied within
its range, keeping other parameters fixed at their optimized values.
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Figure A.5: Evaluating in silico experiments with an alternative ‘synthetic real’ model MST
(A.3B Fig) that is distinct from that used in Figure 2.2. (A) The model is used to generate
synthetic ‘experimental’ results of TF knockout (top row) or strongest site mutagenesis
(bottom row), for each TF, shown in green. These are compared to the synthetic ‘wild-type’
expression profile of ind, shown in black (in each panel). Magenta curves show the average
prediction of the filtered ensemble for each of these ‘experiments’. (B) Information gain due
to each synthetic perturbation experiment, with semantics analogous to those in Figure 2.2
B, under the alternative ‘synthetic real’ model MST.
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Figure A.6: Filtered ensembles for sim perturbation experiments. The wild-type ensemble
was filtered to retain only models that correctly predict the observed effects of an additional
perturbation experiment (A.2 Table), thus yielding a smaller, filtered ensemble for each
experiment. In each panel, wild-type sim expression is shown in black, pink curves represent
predictions of models in the ensemble and magenta represents a weighted average of the
ensemble predictions. (A) The expression extends to the presumptive mesoderm (B) No
change is observed in the expression when the strongest DL site is mutated. (B) Wild-type
expression was observed in mesectoderm. (C) The expression is abolished when using the 1.5
Kb enhancer sequence. (D) The ventral-most line of cells of the neurogenic ectoderm. Weak
and variable staining is also detected in more ventral regions of early embryos. (E) Weak
expression (”greatly reduced mesectodermal transcription, but a low level of expression was
detectable”). (F) Mesectodermal transcription was abolished. (G) No expression is observed.
(H) The expression is similar to the wild-type expression. (I) The Expression is completely
abolished.
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Table A.1: Perturbation experiments for ind gene, from the literature. For each perturbation
experiment reported in the literature, second column summarizes the effect on ind expression
and the third column reports a criterion that we selected, based on the observed effect, for
determining if a model’s prediction is consistent with that experiment. We used these criteria
to filter the wild-type ensemble of models. Note that expression profiles are described with
the D/V axis being divided into 50 bins, with the ventral-most position being bin 1 and the
dorsal-most position being bin 50.
Experiment (Source
Pubmed ID)
Observation Filtering Criteria for Model Prediction
DL 1 site mut.
(Strongest site muta-
genized.) (22216201)
No change is observed. Predicted expression pattern has at
most 5% error with SSE measure com-
pared to the same models prediction on
the wild-type sequence.




Peak expression is re-
duced by 65%.
Expression is low in all bins outside
bins number 22-28 (average expression
less than 0.01 of the peak). Peak ex-
pression is less than 40% of the wild-
type level.




half of the endogenous
levels.
Expression is low in all bins outside
bins number 22-28 (average expression
less than 0.01 of the peak). Peak ex-







where it matches the
spatial domain of the
DL protein.
Average expression in bins 40-50 is less
than 5% and that in bins 25-35 is
greater than 80% of the maximum ex-
pression.
SNA KO (SNA knock-
out.) (16750631)
No change is observed. Predicted expression has less than 5%






the peak of VND
mesoderm region.
Average expression in bins 1-10 is less
than 5% of the wild-type and it is more
than 80% of the wildtype in bins 20-25.
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Table A.2: Perturbation experiments for sim gene, from the literature. For each perturbation
experiment reported in the literature, second column summarizes the effect on sim expression
and the third column reports a criterion that we selected, based on the observed effect, for
determining if a model’s prediction is consistent with that experiment. We used these criteria
to filter the wild-type ensemble of models. Note that expression profiles are described with
the D/V axis being divided into 50 bins, with the ventral-most position being bin 1 and the




Observation Filtering Criteria for Model Pre-
diction
2.8sim (9840810) Wild-type expression is ob-
served in mesectoderm in one
row of cells on either side of the
embryo.
The peak of expression is at bin
14 and is more than 0.8 in scale
of 1. The average expression in
bins 13-15 is more than 0.3 and
the average expression is less
than 1% in all the other bins.
mesectoderm2.1
(9840810)
No expression Predicted expression profile dif-
fers from a flat line of no expres-




No expression Predicted expression profile dif-
fers from a flat line of no expres-






Peak of predicted expression




Weak expression (”greatly re-
duced mesectodermal transcrip-
tion, but a low level of expres-
sion was detectable”)
The average expression in bins
1-9 is more than 50%of the peak






Predicted expression profile dif-
fers from a flat line of no ex-




Mesectoderm (”did not affect
mesectodermal transcription”)
Predicted expression profile dif-
fers from wild type profile by
SSE score of less than 5%.
mesectoderm
(15128669)
The ventral-most line of cells of
the neurogenic ectoderm. Weak
and variable staining is also de-
tected in more ventral regions of
early embryos.
Average expression in bins 10-15
is greater than 10% of the peak
expression and the average ex-
pression in bins 1-9 is less than
5%.
91
Table A.3: Information gain due to a perturbation experiment following another experiment.
















0 0.90 1.60 1.63 2.66 2.01
DL 3 sites
mut.
0.86 0 1.43 1.06 1.85 1.69
ZLD site
mut.
0.69 0.55 0 1.18 1.43 1.26
CIC site
mut.
0.46 -0.07 0.93 0 0.49 0.22
SNA KO 0.76 0 0.46 -0.23 0 -0.19
VND KO 0.34 0.06 0.51 -0.27 0.04 0
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Figure A.7: (A) Gene expression profile of ind enhancer predicted by different models that
cluster together. Each cluster or group of models is depicted by a separate color and the
plotted expression profile is the average expression predicted from models in that cluster.
(B) The mutation selected in this part hits a perfect ZLD site and has the second largest
predicted impact. (C) Distribution of the sum of squared error (SSE) between wild-type
expression and predicted expression for the mutation shown in (A), across models in each
cluster. (D) Average SSE of predictions made by each cluster of models, for each SNP in
DGRP population.
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Figure A.8: A) Predicted expression profile of individuals in DGRP population is close to
the wild-type expression of ind gene. Predictions are averages over the entire ensemble
of models. (B) Simulated individuals with the same population-wide allele frequencies as
DGRP population do not exhibit compensatory effect of mutations as observed in DGRP
population. Each individual is a point on the scatter plot. The x-axis is the SSE score
between the predicted gene expression profile of the individual and the wild-type expression.
The y-axis is the SSE for a construct that includes only the strongest-effect SNP present in
the individual. (C) Each point in the scatter plot is a SNP from DGRP. The x-axis shows
the predicted strength of the TF binding site that overlaps with the SNP and the y-axis is
the change in SSE score between the model-predicted wild-type and the mutation.
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Figure A.9: (A) Each panel corresponds to an individual in DGRP population. Similar
to figure S2(D), points are the SNPs that the individual carries, colored by the TF whose
predicted binding site overlaps the SNP. The x-axis shows the predicted strength of this
binding site and the y-axis is the SSE score between the model predicted wild-type and the
mutation. (B) Gene expression profile of the ind enhancer genotype for DGRP individuals, as
predicted by the models (pink), compared to known expression profile of wild-type enhancer
(black). Each panel’s title shows the mean and standard deviation (sd), across models, of
SSE scores between the model-predicted profile for the enhancer sequence defined by the
genotype of a particular individual and the wild-type expression.
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Figure A.10: (A) Model-predicted expression profile of “construct1”, the first construct
selected for the experiments, where the SNP selected for the construct lies within a VND
binding site. Each color represents the average prediction of a group of models that cluster
together in the parameter space. (B) The expression profile predicted by a select group of
models (‘final ensemble’) suggests little impact of the SNP on expression. (C) SSE score
(between wild-type expression and model-predicted expression for the construct) for each
group of models and the number of models in that group. The magenta boxplot, with the
lowest SSE scores, corresponds to the final ensemble. (D) Similar to A, but for “construct2”;
this construct carries a mutation in DL binding sites and most models predict an impact on
the gene expression. (E) The final ensemble predicts no change in the gene expression for
this construct. (F) The SSE score of the magenta cluster is the lowest. (G) Similar to A
and D, but for “construct3”; this construct carries two mutations in DL binding sites that
are potentially compensatory. Most models predict no change in the gene expression for
this construct. (H) The final ensemble predicts no change in the gene expression for this
construct. (I) Similar to C and F, the magenta cluster has the lowest SSE scores among all
groups of models.
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Figure A.11: Each panel shows wild-type rho profile (black), expression profile of the syn-
thetic enhancer (name provided in panel title) (red), and expression profile for that enhancer
as predicted by one or more clusters of models. (A, C, E, G) Predicted expression profiles
correspond to each cluster of models. (B, D, F, H) Predicted expression profile represents
the special cluster of models called the final ensemble. Enhancers in (A, B) represent DL
site mutagenesis, (C, D) represent DL and TWI site mutagenesis, (E, F) represent BHLH
site mutagenesis and (G, H) represent TWI site mutagenesis.
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Figure A.12: Similar to Figure S5, except that these represent synthetic variants of the rho
enhancer where SNA binding sites have been mutagenized. Wild-type expression profile
(black) and experimental expression profile of the synthetic enhancer (red) are compared to
model-predicted profiles from (A) each cluster of models or (B) only the models in the final
ensemble.
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Figure A.13: (A-F) Models trained on wild-type ind enhancer are filtered based on their
ability to predict the effects of perturbations. Expression profiles in wild-type and pertur-
bation conditions are shown in black and green respectively, and predictions made by each
cluster of models in the ensemble are shown in other colors in adjacent panels. (G) Twelve
models survive 5 of the 6 filters depicted in A-F, but no model simultaneously predicts the
effect of perturbations denoted by “ZLD sites” (mutagenesis of four ZLD sites) and “DL 3
sites” (mutagenesis of three DL sites). The peak expression levels in these two conditions
are shown by the green star, while other points represent peak expression levels in these two
conditions as predicted by the 12 above-mentioned models. The x-axis is the peak expres-
sion level (real or predicted by a model) for the “DL sites” mutagenesis condition and the
y-axis is the peak expression level for the “ZLD sites” mutagenesis condition. (H) Regions
of parameter space around the 12 above-mentioned models are sampled densely. Shown is a
PCA-based two-dimensional representation of these models.
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Table A.4: Liver tissue validations. The number of overlaps from the enrichment tests. The
size of all eQTL set in Liver is 207822. The number of overlaps with H3K27ac broad peaks
is 9877 and narrow peaks is 5408. The number of eRNAs overlap is 453. The first four rows
of the table reports the actual number of overlaps and the last three rows are the − log10 p
where p is the p-value of the hyper-geometric test.
Liver
baseline PGM Expected baseline PGM Expected
#Genes 76 517 94 614 1249 239
#SNPs 100 100 100 995 1000 1000
#TFs 15 15 19 19
#H3K27ac-
broad
24 30 4.75 209 230 47.52
#H3K27ac-
narrow








7.28 2.91 0.77 29.71 8.37 1.60
eRNA-
Pvals
0.71 5.51 0.22 2.84 20.78 3.06
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Table A.5: Colon tissue validations. The size of all eQTL set is 417338. The number of
overlaps with H3K27ac broad peaks is 30462 and narrow peaks is 13577. The number of
eRNAs overlap is 779.
Colon
baseline PGM Expected baseline PGM Expected
#Genes 46 175 774 1155
#SNPs 100 100 100 1000 1000 1000
#TFs 14 20 20 20
H3K27ac-
broad
23 25 7.23 239 256 72.99
H3K27ac-
narrow
16 7 3.25 143 96 32.53








7.59 1.78 0.16 40.08 20.26 0.34
eRNA-
Pvals
0.94 0.94 0.76 0.54 11.82 0.49
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Table A.6: Heart tissue validations. The size of all eQTL set is 471757. The number of
overlaps with H3K27ac broad peaks is 21896 and narrow peaks is 14884. The number of
eRNAs overlap is 848.
Heart
baseline PGM Expected baseline PGM Expected
#Genes 65 207 718 1200
#SNPs 100 100 100 995 1000 1000
#TFs 14 20 20 20
H3K27ac-
broad
25 26 5.25 217 266 52.47
H3K27ac-
narrow
21 16 3.57 179 93 35.64








12.20 7.78 0.57 78.62 19.60 3.75
eRNA-
Pvals
0.78 0.78 0.98 0.78 0.57 0.58
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Table A.7: Lung tissue validations. The size of all eQTL set is 775469. The number of
overlaps with H3K27ac broad peaks is 31233 and narrow peaks is 20016. The number of
eRNAs overlap is 1185.
Lung
baseline PGM Expected baseline PGM Expected
#Genes 46 170 774 1571
#SNPs 100 100 100 1000 1000 1000
#TFs 11 19 19 19
H3K27ac-
broad
25 26 4.02 348 343 40.28
H3K27ac-
narrow
13 4 2.58 172 93 25.81








6.50 0.93 0.46 85.77 25.50 0.35
eRNA-
Pvals
0.85 0.85 1.00 0.35 1.16 0.52
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